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Effects of Cognitive Bias Modification- Interpretation (CBM-I) Interventions 
on Depressive Symptoms: A Systematic Review 
Abstract 
Depression is a major source of disability and many people do not access 
treatment. More accessible, cost-effective treatments are required. Cognitive 
bias modification interventions that target interpretation biases, hypothesised to 
contribute to the development and maintenance of depression, have been 
identified as a promising treatment. The current systematic review aimed to 
examine effects on symptoms of depression, in clinical and analogue samples, 
of cognitive bias modification interventions that have targeted interpretation 
biases. Relevant studies were sourced using a systematic search of databases 
and by contacting researchers involved in cognitive bias modification research. 
Ten relevant studies were identified, nine of which were classified as 
randomised controlled trials. Data relating to participants, interventions, 
comparator groups, outcome measures, study design, study quality, and 
findings relating to the interventions’ effects on symptoms of depression and 
cognitive bias were extracted and synthesised. The overall picture of the effect 
of the interventions on symptoms of depression and interpretation bias was 
mixed, suggesting cognitive bias modification interventions that target 
interpretation biases are not currently at a stage to be recommended as an 
evidence-based treatment for depression. Limitations of the studies and review 
were acknowledged. Identification of the most meaningful outcome measures 
and effective CBM-I paradigm, perhaps a non-verbal design to maximise 
accessibility, paired with further rigorous studies are recommendations for 
further research in this field. 
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Introduction 
Depression 
Depression is a major cause of disability worldwide, accounting for 4.3% of 
the global burden of disease (World Health Organization, 2013). These burdens 
include increased risk of mortality, especially by suicide, and disruptions to 
family stability, leading to family breakdown (Lépine & Riley, 2011). Depression 
contributes to workplace absenteeism, an economic burden for society 
(Karampampa, Borgström, & Jönsson, 2011). Depression is characterised by 
persistent low mood and loss of interest in activities, accompanied by changes 
in psychomotor activity, sleep, and appetite, lack of energy, feelings of 
worthlessness, concentration difficulties, and suicidal ideation (American 
Psychiatric Association, 2013). Many cognitive theories of the aetiology, 
maintenance and risk of relapse of depression emphasise the role of negative 
cognitive biases, whereby people with depression tend to be drawn to negative 
stimuli and interpretations. 
Negative cognitive bias is central to this review, investigating the effect of 
cognitive bias modification (CBM) interventions on symptoms of depression. 
Negative biases have been found to occur at different levels of information-
processing including attention, interpretation, and memory (Mathews & 
MacLeod, 2005). CBM paradigms focusing on these cognitive processes are 
known as CBM-A, CBM-I, and CBM-M, respectively. Compared to people 
without depression, people with depression more selectively attend to and recall 
negative stimuli, and interpret ambiguous situations more negatively. Beck and 
colleagues (1979) developed a model of depression, suggesting people with 
depression view the self, world and future more negatively than others; this 
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model underpins traditional cognitive therapy, which aims to identify and reduce 
these negative biases. 
Evidence-based treatments for depression include cognitive behavioural 
therapy (CBT) and antidepressants; both treatments are linked to changes in 
information-processing biases hypothesised to mediate changes in mood. CBT 
modifies interpretation biases, through thought-challenging and considering 
alternative interpretations of situations. A recent neurocognitive model of the 
mechanism of antidepressants (Harmer, Goodwin, & Cohen, 2009) suggests 
medication leads to neurochemical changes causing early modification of 
information-processing biases, detectable shortly after administration, and this 
mediates later improvements in mood. Antidepressants are less acceptable 
than psychological therapies to many people (e.g., Chabrol, Teissedre, 
Armitage, Danel, & Walburg, 2004) and psychological therapies are not 
accessible to everyone. Barriers include lack of skilled therapists, limited clinic 
opening times, and treatment costs (Titov et al., 2010). It is therefore desirable 
to develop accessible, acceptable, cost-effective treatments to tackle problems 
caused by depression.  
CBM-I 
Development of accessible treatments for depression has included 
successfully adapting CBT to be computerised (cCBT; Andrews, Cuijpers, 
Craske, McEvoy, & Titov, 2010). CBM has been proposed as a promising 
treatment. CBM aims to modify or induce cognitive biases through repeated 
exposure, without extensive instructions, to simple stimuli via computer 
software. CBM was initially implemented as an experimental task to test 
hypotheses that negative cognitive biases contributed causally to mental health 
problems. For example, anxiety increased in healthy volunteers after a CBM 
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paradigm reinforced negative interpretation biases (Mathews & Mackintosh, 
2000). The success of CBM in modifying cognitive biases in healthy populations 
highlighted its potential as a mental health intervention. This review considers 
the potential of CBM to reduce symptoms of depression by a similar mechanism 
to the models outlined above of the action of CBT and antidepressants. 
The majority of CBM studies have targeted negative attentional biases in 
anxiety. CBM research in depression is in its infancy (Torkan et al., 2014). 
Nevertheless, two meta-analyses have considered effectiveness of CBM in 
treating mental health conditions. Hallion and Ruscio (2011) examined effects of 
CBM-I and CBM-A on anxiety and depression in 45 studies. CBM interventions 
had a large effect in modifying interpretation biases and a medium effect on 
attention biases. Regarding depression, they concluded there was no evidence 
of CBM interventions modifying depression; this was based on a non-significant, 
small, unreliable effect. Limitations were that only 10 of the 45 studies used a 
depression measure. Only three investigated an analogue or clinical sample of 
people with depression, using CBM-A. The other seven measured depression in 
analogue or clinical samples of people with anxiety, and used a CBM paradigm 
designed specifically to target biases associated with anxiety, rather than 
depression. Conclusions of the effectiveness of CBM interventions on 
depression should be made cautiously in the context of these limitations.  
A more recent meta-analysis (Menne-Lothmann et al., 2014) investigated 
effects of CBM-I on positive interpretations and mood. Different aspects of 
interpretation bias have been targeted by various CBM-I interventions, using 
homophones, word-sentence association tasks, ambiguous situations, and 
emotion recognition. The meta-analysis found CBM-I, which reinforced benign 
and positive interpretations, decreased negative mood. Bigger effects were 
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found when CBM-I paradigms encouraged participants to use mental imagery, 
and also for female participants, or when the number of sessions was greater. 
These findings do not have a high level of external validity when generalizing to 
people with symptoms of depression because the meta-analysis combined 
studies using anxiety and depression paradigms to examine healthy volunteers 
and analogue and clinical samples of people with anxiety and depression. The 
current review, in a similar design to that of Menne-Lothmann and colleagues 
(2014), only examined CBM-I studies, rather than other CBM paradigms. 
Objective 
The current systematic review aimed to examine effects of CBM-I on 
depression symptoms. To overcome limitations identified in the previous 
reviews, only studies that have used CBM-I with analogue or clinical samples 
with dysphoria or depression were examined. CBM-I, theoretically, has great 
potential in targeting negative biases that occur in depression to mediate 
changes in mood. Understanding the effectiveness of CBM-I interventions 
developed thus far is essential for treatment development and dissemination. 
The review question was, “What are the effects of CBM-I interventions on 
symptoms of depression of people with depression or dysphoria?” 
Method 
Search Strategy 
Electronic database searches were carried out in July 2014 using Web of 
Science, PsycINFO, PubMed, Medline, Psycarticles, and The Cochrane Library 
to find papers published between 1994 and 2014. The search terms were 
(depress*, OR dysphori*) AND (cognitive bias modification, OR interpret* bias 
modification, OR interpret* training, OR bias training OR bias modification). 
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Additional search strategies included contacting experts in the field of CBM for 
information about unpublished or other relevant literature, and hand-searching 
reference lists of key articles. 
The researcher carried out a systematic approach to identify appropriate 
studies (Figure 1). Duplicate studies were removed, titles and abstracts 
examined, then full-text of the remaining studies was screened to ensure 
fulfilment of the eligibility criteria. Data were extracted based on the PICOS 
framework, i.e., considering participants, intervention, comparators, outcomes, 
and study design. Issues of study quality were examined using guidelines 
outlined in the PRISMA statement (Moher, Liberati, Tetzlaff, & Altman, 2009) to 
assess risk of bias for each study. 
Eligibility Criteria 
Studies were eligible if they met the following criteria. Participants had 
dysphoria or depression, i.e., analogue or clinical samples. Participants of all 
ages and from all countries were considered. Outcomes included a depression 
measure, assessing changes in mood. The intervention used a CBM-I design, 
as defined by Koster, Fox, and MacLeod (2009). Specifically, the intervention 
aimed to directly modify an interpretation bias, not through following detailed 
instructions but instead through intensive practice on a simple, repetitive, 
cognitive task designed to facilitate the desired cognitive change. Eligible 
publication dates were 1994 to 2014, since the field of CBM research began 
around 2000 (Fox, Mackintosh, & Holmes, 2014). There were no publication 
status restrictions. 
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Study Synthesis Strategy 
Studies were considered in terms of similarities and differences of design, 
participants, comparators, outcomes, and CBM-I interventions. Issues of study 
bias were also explored. To examine the objective of the review, investigating 
the effectiveness of CBM-I on depressive symptoms, the study findings relating 
to depression and interpretation bias outcomes were evaluated. 
Results 
Study Characteristics 
Ten studies were identified for the review (Table 1).  
Study Designs 
All studies were described as randomised controlled trials (RCTs) except the 
earliest dated study, a single case-series (Blackwell & Holmes, 2010). RCTs 
represent the gold-standard in evaluating healthcare interventions, when well-
designed, conducted and reported (Schulz, Altman, & Moher, 2010), therefore 
they have greater external validity than the case-series. Two studies were 
described as pilot-studies (Lang, Blackwell, Harmer, Davison, & Holmes, 2012; 
Torkan et al., 2014). Follow-ups, a component of good quality studies, were 
implemented by all studies. The follow-up findings from the study by Williams 
and colleagues (2013), however, will not be considered in this review because 
the outcomes are confounded by a 10 week web-based CBT intervention 
implemented after the CBM-I intervention. 
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title and abstract 
(n = 224) 
Records excluded 
(n = 147) 
Full-text articles 
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*No depression 
outcome measure        
(n = 16) 
*No CBM-I intervention  
(n = 10) 
*Not 
dysphoric/depressed 
participants (n = 41) 
Studies included in 
qualitative synthesis 
(n = 10) 
Full-text articles 
assessed for eligibility 
(n = 77) 
Figure 1. PRISMA flowchart of study selection.  
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Study 
Number. 
Authors: 
Study 
Centre 
Study 
Designs 
Participants CBM-I Positive 
Intervention 
Paradigms 
Comparators Outcomes Findings (p < .05) 
1. Blackwell 
et al., 
(2014): 
Oxford, UK. 
RCT. 1, 3, 
& 6 month 
follow-up. 
MDD (SCID-
I). N=150. 
Average 
age:35.  
Multi-paradigm: 
auditory (6 
sessions) & 
picture-word (6). 4 
weeks at home. 
Half 
negative, half 
positive 
stimuli. 
(a) BDI-II & SST 
(b) Clinically significant change 
on BDI-II 
(c) Anhedonia (i.e., BDI-II 
items 4 & 12) 
(d) Moderating effect of 
number of episodes of 
depression on BDI-II 
(e) Moderating effect of 
vividness of imagining the 
CBM-I scenarios on BDI-II 
(f) Relationship between 
(a) No time*condition interaction 
(b) No group difference 
(c) Greater reduction for positive v. control group 
at post intervention (not all time-points) 
(d) Subgroup with < 5 depressive episodes had 
a greater reduction on BDI-II in the positive vs 
control condition, at post-intervention & 1-month 
follow-up (not other time-points) 
(e) Greater reduction on BDI-II with higher 
vividness scores, within the positive v. control 
group at all time-points 
 (f) Change in SST predicted change in BDI-II 
Table 1  
Studies investigating effectiveness of CBM-I interventions in reducing depressive symptoms in people with depression or dysphoria 
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change in bias (SST) and 
mood (BDI-II). 
  
score (pre-post). Post-intervention SST score 
correlated with BDI-II score at 3 & 6 month 
follow-up (not 1 month): 
 
2. Blackwell 
& Holmes 
(2010): 
Oxford, UK. 
Single case 
series: A-B 
design. 2 
week 
follow-up 
MDD (SCID-
I). N=8. 
Average 
age:38. 
Auditory: 7 days 
at home. 
Week prior to 
intervention 
used as 
control. 
(a) BDI-II, PANAS, SST, VAS 
(depressive statements) 
(a) Improved mood & cognitive bias for 4 out of 
7 participants that was maintained at follow-up, 
3 found difficulties engaging with the CBM-I 
intervention, 1 excluded. 
 
3. Lang et 
al., (2012): 
Oxford, UK. 
RCT (pilot). 
2 week 
follow-up 
MDD (SCID-
I). N=28. 
Average 
age:29.  
Multi-paradigm: 
auditory (3 
sessions), picture-
word (2), word-
fragment 
appraisal (1), 
mixed session (1). 
1 week at home. 
Half 
negative, half 
positive 
stimuli. 
(a) BDI-II, Ham-D, IES, SST & 
RIQ, post-intervention 
(b) BDI-II, at follow-up 
(c) Clinically significant change 
on BDI-II & Ham-D post-
intervention 
(d) Clinically significant change 
(a) Decreased depressive symptoms & negative 
cognitive bias for positive group, not control 
group  
(b) Time*condition interaction at trend level: 
decrease for positive group not control  
(c) More positive group participants than control 
group, at post-intervention 
(d) More participants, at trend level, for positive 
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on BDI-II at follow-up 
(e) Correlation between 
change in interpretation bias 
(RIQ & SST) and depression 
(BDI-II)  
group vs control 
(e) BDI-II change positively related with RIQ (at 
trend level with SST) for positive not control 
group, at post-intervention. 
 
4. Micco et 
al., (2014): 
Boston, 
USA. 
RCT. 2 
week 
follow-up 
BDI-II > 13.     
N = 45. 
Average 
age:18. 
Word-fragment: 
scenarios relevant 
to potential loss, 
rejection or 
failure. 4 sessions 
over 2 weeks in 
lab. 
Unambiguou
s, 
emotionally 
neutral 
stimuli. 
(a) TIB 
(b) TIB: limited to the subgroup 
with a baseline negative bias 
(i.e. a score below 1.0) 
(c) DAS  
(d) CANTAB: AGN 
(e) BDI-II & MDD symptoms 
(SCID-IV/K-SADS-E). 
(a) No time*condition interaction 
(b) Time*condition interaction mid-treatment at 
trend level post-treatment (not at follow-up): 
increased positive bias for positive vs control 
group  
(c) Greater reduction for positive vs control 
group at post-intervention & follow-up  
(d) No time*condition interaction 
(e) No time*condition interaction. 
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5. Newby et 
al., (2014): 
Sydney, 
Australia. 
Non-
randomised 
controlled 
trial. 1 
week 
follow-up. 
BDI-II > 12.     
N=60. 
Average 
age:26.  
Word-fragment: 
appraisal of 
intrusive 
memories. Single 
session in lab. 
1. CBT: 
single 
session. 2. 
No 
intervention. 
(a) BDI-II, IES, & Appraisals of 
Intrusive Memories 
Questionnaire, at follow-up 
(b) PANAS, post-intervention 
(c) IMI 
(d) Intrusive Memory Diary, 
completed at home over a 
week 
(e) Correlation: bias & mood 
 
(a) No time*condition interaction 
(b) No difference between groups 
(c) No difference between CBM group vs control 
or CBT 
(d) No difference between groups 
(e) Reduction in negative appraisal (baseline – 
follow-up) correlated with reduction of distress. 
6. Penton-
Voak et al., 
(2012): 
Bristol, UK. 
RCT with 2 
week 
follow-up 
BDI-II > 13.     
N=80. 
Average 
age:21. 
Morphed faces: 4 
sessions in lab. 
Sham-
training. 
(a) PANAS (positive, follow-up) 
& CBM-I face-morph final 
threshold (post-intervention) 
(b) PANAS (negative) & BDI-II, 
at follow-up. 
 
(a) Increased positive affect & positive bias for 
positive group vs control 
(b) No significant difference. 
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7. Pictet et 
al., (2011): 
Oxford, UK. 
RCT with 
24 hour 
follow-up. 
BDI-II > 10.     
N=81. 
Average 
age:28.  
Picture-word: 
Single session in 
lab. 
1. Half 
negative, half 
positive 
stimuli 
2. All 
negative. 
(a) PANAS (positive affect) & 
Fish Game, post-intervention 
(b) Homophone Task, at 24-
hours follow-up. 
(a) Increased positive affect & behavioural 
motivation for positive CBM-I group vs 
comparators 
(b) Increased positive bias for positive CBM-I 
group vs negative group, not positive vs half 
negative/half positive group. 
 
8. Torkan 
et al., 
(2014): 
Isfahan, 
Iran. 
RCT (pilot) 
with 2 week 
follow-up. 
MDD (SCID-
I). N=39. 
Average 
age:28. 
Auditory (Persian 
version): with use 
of imagery vs 
non-imagery. 7 
days at home. 
No 
treatment. 
(a) BDI-II, at post-intervention 
(b) SST & RRS, at post-
intervention 
(c) BDI-II, at follow-up 
(d) SST, at follow-up 
(e) RRS, at follow-up 
(f) Clinically significant change 
on BDI-II  
(g) Relationship: change in 
(a) Decrease in depressive symptoms for both 
CBM-I groups, not control. Greater decrease for 
imagery group than non-imagery, not between 
non-imagery & control 
(b) Decrease in negative interpretation & 
ruminative responses in imagery group, not non-
imagery CBM-I condition or control  
(c) Decrease in depressive symptoms from 
baseline (not post-intervention) for imagery 
group, not non-imagery CBM-I condition 
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bias (SST) & mood (BDI-II)  
 
(d) Decrease in negative interpretation bias for 
imagery CBM-I group, increase in negative 
interpretation for non-imagery CBM-I group 
(e) No time*condition interaction 
(f) More participants in imagery CBM-I group 
than non-imagery group, at post-intervention 
and follow-up 
(g) Change in BDI-II correlated with change in 
negativity score on SST (pre-post). 
 
9. Williams 
et al., 
(2013): 
Sydney, 
Australia. 
RCT. MDD (MINI). 
N=69. 
Average 
age:45. 
 
Auditory: 7 days 
at home. 
Wait list 
control. 
(a) BDI-II, PHQ-9, K10, AST-D 
(b) SST 
(c) Clinically significant change 
on BDI-II  
(d) Relationship: change in 
bias (AST-D) & mood (BDI-II). 
(a) Increased symptom reduction & more 
positive bias for positive group vs control 
(medium effects) 
(b) No interaction of time*condition 
(c) More participants, at trend level, for positive 
group vs control  
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 (d) AST-D change score (pre-post) was a 
significant mediator of condition (CBM-I vs 
control) on BDI-II change score, i.e., change in 
interpretation, at least in part, mediated 
reduction in depression symptoms following 
CBM-I 
 
10. Yiend 
et al., 
(2013): 
London, 
UK. 
RCT. 4 
week 
follow-up. 
MDD (MINI). 
N = 40. 
Average 
age:43.  
Word-fragment: 
prompt positive 
future directed 
cognition to CBM-
errors. A single 
lab session. 
Unambiguou
s, 
emotionally 
neutral 
stimuli. 
(a) SRT, post-intervention 
(b) SST, post-intervention 
(c) VAS sad/anxious: change 
after watching short film, 
intended to induce stress 
(d) BDI-II, PANAS, & MDI, at 
follow-up 
(e) ATQ-R, at follow-up. 
(a) More positive bias for positive vs control 
group. 
(b) Significant time*condition interaction when 
means imputed for missing data, n = 3. Increase 
in positive bias for positive group not control 
group. Decrease in negative bias, at trend level 
(at significance when means imputed for missing 
data), for positive group not control group. 
(c) No time*condition interaction. 
(d) No time*condition interaction. 
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Note. AST-D = Ambiguous Scenarios Test for Depression; ATQ-R = Automatic Thoughts Questionnaire-Revised; BDI-II = Beck Depression Inventory-II; 
CANTAB: AGN = CANTAB: Affective Go/No-Go Test; CBM-I = cognitive bias modification for interpretation bias; CBT = cognitive behavioural therapy; 
DAS = Dysfunctional Attitudes Scale ; IES = Impact of Event Scale; K10 = Kessler Psychological Distress Scale; K-SADS-E = Kiddie-Schedule of 
Affective Disorders and Schizophrenia-Epidemologic Version; IMI = Intrusive Memory Interview; Ham-D = Hamilton Depression Ratings Scale; KSADS-
E = ;MDI = Major Depression Inventory; MINI = Mini International Neuropsychiatric Interview Version 5.0.0; PANAS = Positive and Negative Affect 
Scale; RCT = randomised controlled trial; MDD = major depressive disorder; PHQ-9 = Patient Health Questionnaire – 9 item Depression Scale; RIQ = 
Response to Intrusions Questionnaire; RRS = Ruminative Responses Scale; SCID-I = Structured Clinical Interview for DSM-IV; SRT = Similarity 
Ratings Test; SST = Scrambled Sentence Test; TIB = Test of Interpretation Bias; UK = United Kingdom; USA = United States of America; VAS = visual 
analogue scale.
(e) No difference between groups. 
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Participants 
The majority of study participants were Caucasian females, limiting 
generalizability of findings to the global population. One study recruited 
adolescents and young adults (Study 4), another recruited participants aged 18 
to 45 (Study 6). All other studies recruited adults from a wider age range. Six 
studies (1, 2, 3, 8, 9, & 10) recruited only participants with a major depressive 
disorder. Four studies recruited participants with dysphoria (4, 5, 6, & 7). All 
studies reported detailed information of inclusion and exclusion criteria, and 
similarities in baseline data across conditions, showing good levels of validity in 
the study samples and transparency in reporting. 
Interventions 
Four different CBM-I paradigms were implemented. All were computerised 
interventions aimed at reinforcing, through repeated presentation of simple 
stimuli, a more positive bias for interpreting ambiguous situations. 
Heterogeneity of these CBM-I interventions raises the question whether the 
mechanism by which they work is the same, whether they have similar effects, 
and whether they are best measured using the same outcomes. Research into 
CBM-I for depression is relatively new, so investigating multiple paradigms is 
sensible in the quest to find an effective intervention. 
One paradigm, implemented by five studies (1, 2, 3, 8, & 9), involved 
auditory presentation of initially ambiguous scenarios, which had a positive 
resolution. Another paradigm, implemented by three studies (1, 3, & 7), involved 
pictures of ambiguous scenes displayed alongside a positive word. A third 
paradigm, implemented by four studies (3, 4, 5, & 10), required participants to 
read short paragraphs, initially ambiguous in content, ending with a word 
fragment, which participants were asked to amend, creating a forced positive 
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resolution. The fourth paradigm, implemented by one study (6), involved brief 
presentations of faces, on a morphed sequence from sad to happy. Participants 
received feedback to shift interpretations of the ambiguous faces from sad to 
happy. 
Over the ten studies, the number of sessions implemented ranged from one 
to twelve. Two studies used a multi-paradigm intervention (1 & 3). Five 
implemented the intervention in a laboratory setting (4, 5, 6, 7, & 10). The other 
five implemented interventions in participants’ homes (1, 2, 3, 8, & 9); four 
studies initially invited participants to a laboratory setting (1, 2, 3, & 8), only one 
study (9) involved no face-to-face contact.  
Comparators 
Six studies included a comparator similar in design to the positive CBM-I 
paradigm implemented (1, 3, 4, 6, 7, & 10). These comparators consisted of 
control stimuli that were (a) unambiguous and emotionally neutral (4 & 10) (b) 
half negative and half positive (1, 3, & 7) or (c) all negative (7); as opposed to 
the positive CBM-I interventions in which the majority of stimuli were ambiguous 
and positively biased. Presentation of only negative stimuli as a control 
condition could be considered ethically questionable, particularly with 
participants who are depressed. Sham-training was the comparator 
implemented by one study (6); control group participants received feedback to 
reinforce their baseline thresholds.  
Other comparators were no-treatment control conditions (5, 8, & 9). When 
examining differences between a positive CBM-I intervention and a no-
treatment condition many more confounding factors are present than comparing 
a positive CBM-I intervention with a CBM-I control condition. In the case-series 
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study (2), the week before participants began the CBM-I program was used as 
a control period. One study (5) compared a different treatment paradigm: a 
therapist-delivered CBT session, aiming to target and modify negative 
interpretation biases.  
Outcomes 
All ten studies included at least one outcome measuring depressive mood 
and one measuring interpretation bias, the relevant study outcomes for this 
review.  
Depressive mood. 
All studies, except one (7) used the Beck Depression Inventory-II (BDI-II; 
Beck, Steer, & Brown, 1996), a gold-standard self-report measure of 
depression. Use of the same outcome measure facilitates comparisons 
between studies. The majority of depressive mood outcomes were self-report 
measures. Two studies implemented clinician-administered assessments of 
depressive mood (3 & 4). Clinician-administered assessments have been 
described as more accurate at measuring depressive severity than self-report 
measures but less able to detect change in mild levels of depression (Cusin, 
Yang, Yeung & Fava, 2010).  
Two other outcomes were implemented, a novel behavioural task using a 
fishing game to measure motivated behaviour (7), and visual analogue scales 
(VAS) measuring sadness and anxiety to assess mood changes after 
participants watched a short video of a life-threatening incident, simulating a 
stressful experience (10). These outcomes, arguably, have less robust 
psychometric properties but more ecological validity in measuring symptoms of 
depression than self-report measures, such as the BDI-II and clinician-
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administered assessments, such as the Hamilton Depression Rating Scale 
(Ham-D; Hamilton, 1960).  
Interpretation bias. 
Six studies (1, 2, 3, 8, 9, & 10) measured interpretation bias using the 
Scrambled Sentences Test (SST; Wenzlaff, 1993), a predictor of depressive 
symptoms (Rude et al., 2002). Six other tests of interpretation bias were 
implemented (see Table 1). A further measure of interpretation bias utilised 
visual analogues scales (VAS) associated with depressive statements (2), and 
three self-report measures were utilised. No single standard measure of 
interpretation bias has yet emerged. The heterogeneity of measures makes 
comparing findings difficult. 
Study Quality and Issues of Bias 
Nine of the reviewed studies claimed to be RCTs (1, 3, 4, 5, 6, 7, 8, 9, &10). 
One study (5) did not use a true randomisation procedure, alternately allocating 
participants to different conditions; three studies did not describe randomisation 
procedures (4, 7 & 8). Four studies (1, 4, 6, & 10) reported that condition 
allocation was concealed to reduce bias. Only one study collected a full set of 
data (7). Two studies moderated the risk of bias caused by attrition, clearly 
reporting flow of participants and appropriately using intention-to-treat analyses 
(1 & 9). While all study reports clearly described many issues relating to 
methodology, not all clearly identified the study hypotheses and primary 
outcome; four studies were transparent on this issue (1, 4, 8, & 9). One study 
(9), however, identified five measures as primary outcomes. When considering 
all of these issues of quality and bias, the most rigorous study (1) was 
implemented by Blackwell and colleagues (2014).  
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Study Findings 
 The findings presented are based on statistical tests where the 
probability of obtaining the results by chance was <.05, some findings are 
reported that were at trend level. Improvement in scores over time could be 
caused by regression to the mean; findings are therefore only reported if there 
was evidence of a greater improvement compared to a control group, not just a 
main effect of time. 
Changes in depressive symptoms. 
Reductions in depressive mood for groups allocated to the positive CBM-I 
intervention were found in eight studies. The most rigorously implemented study 
(1), using a 12-session multi-component CBM-I home intervention, found no 
evidence to support the a priori hypothesis regarding reduction in BDI-II score. 
Reductions in anhedonia were found: Cohen’s d = 0.41 between groups post-
intervention, a 0.54 difference on a 0 to 6 scale. Subgroup analyses revealed 
improvements on BDI-II score for participants with less than five depressive 
episodes; d = 0.73 between groups, a 6.9 difference post-intervention and 6.6 
at 1-month follow-up on the BDI-II scale of 0 to 63. BDI-II score also improved 
for participants who could vividly imagine the CBM-I stimuli. 
Three studies, using different positive CBM-I interventions, found evidence 
to support improvements on all included depression outcomes (3, 9, & 7). One 
such study (3) piloted a similar multi-paradigm design to the most rigorous study 
(1) but with less rigour and statistical power, a shorter intervention, and shorter 
follow-up; findings included significant reductions in depressive symptoms 
measured by the BDI-II (d = 0.89 within the positive group, a 6.85 difference), 
Ham-D (d = 1.24, a 4.92 difference on a 0 to 54 scale), and Impact of Event 
Scale (IES; Horowitz, Wilner & Alvarez, 1979; d = 1.34, a 8.62 difference on a 0 
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to 40 scale). Furthermore, more participants in the positive CBM-I group were 
found to have significant levels of clinical change on the BDI-II and Ham-D, 
compared with participants allocated to a control CBM-I group presented with 
half positive and half negative stimuli. The second study (9) compared a 7-day 
auditory CBM-I home intervention with a wait-list group; significant 
improvements were found on the BDI-II (a 5.83 difference between groups), 
Patient Health Questionnaire 9-item depression scale (Kroenke, Spitzer & 
Williams, 2001; a 1.72 difference on a 0 to 27 scale), and Kessler Psychological 
Distress Scale (Kessler et al, 2002; a 4.86 difference on a 10 to 50 scale). 
Medium effect sizes were reported for each improvement. The third study (7) 
used a single picture-word laboratory-based CBM-I session; significant 
increases in positive affect were found, measured by the Positive and Negative 
Affect Scales (PANAS; Watson, Clark & Tellegen, 1988; d = 0.77 between the 
positive CBI-I group and mixed CBM-I group, a difference of 7.71 on an 
unspecified PANAS scale, and a difference of 14.89 between the positive and 
negative CBM-I groups). The study also found increased behavioural motivation 
and persistence, negatively associated with dysphoria; this was measured by 
the fishing task, which was a toy requiring participants to use a small plastic rod 
to catch as many small fish as possible in 2.5 min. The positive CBM-I group 
caught 3.15 more fish than the mixed CBM-I group (d = 0.75) and 5.78 more 
than the negative group (d = 1.38). 
The three studies that implemented a word-fragment CBM-I intervention, as 
a single-paradigm design, showed limited evidence for reducing depressive 
symptoms (4, 5, & 10). One study (4) found no greater reduction in depressive 
symptoms for the intervention group, following a 4-session laboratory-based 
CBM-I intervention, compared to the control group, measured by the BDI-II, and 
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a clinician-administered assessment. However, there was a reduction, post-
intervention and at follow-up, on the Dysfunctional Attitudes Scale (DAS; 
Weissman & Beck, 1978), which measured depressive beliefs relating to 
perfectionism and the need for social approval (d = 0.60 between groups post-
intervention, a 17.97 difference on a 40 to 280 scale; d = 1.02 at follow-up, a 
30.92 difference). The DAS could be more sensitive to specific changes. This 
finding could also be a Type I error, since many different outcome measures 
were used. Two studies (5 & 9) used a similar intervention design but different 
participant inclusion criteria and different comparison conditions; neither found 
evidence for the superiority of positive CBM-I in reducing depressive symptoms 
on any mood measure. 
The only study that used the face-morph CBM-I paradigm (6) measured 
depression symptoms 2 weeks following four laboratory-based sessions; 
evidence was found for improved positive affect, measured by the PANAS (a 
3.29 adjusted mean difference on a 10 to 50 scale), but not for reduced 
negative affect or BDI-II score.  
One study (8) compared a no-treatment group with two 7-day home-based 
positive CBM-I interventions using an auditory paradigm: one group used field 
perspective imagery; the other did not use imagery. The imagery group was 
superior to the non-imagery group, which was in turn superior to the no-
treatment group in reducing depressive symptoms. The adjusted mean 
difference in BDI-II score between imagery and non-imagery group was 8.54 
post-intervention (d = 1.11), 13.0 at follow-up (d = 1.75), and 9.85 between 
imagery and control group post-intervention (d = 1.04). The difference in score 
on the Ruminative Responses Scale (Nolen-Hoeksema & Morrow, 1991) post-
intervention between the imagery and non-imagery group was 15.77 on a 22 to 
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88 scale (d = 1.0), and 17.0 between the imagery and control group (d = 1.13). 
Finally, the case-series study (2), using a 7-day home-based auditory CBM-I 
intervention, showed reductions in depressive symptoms for four of seven 
participants. Qualitative data indicated responsive participants had more fully 
engaged with the intervention than non-responders.  
Changes in interpretation bias. 
Increased positive interpretation bias or decreased negative bias for groups 
allocated to the positive CBM-I intervention, compared to comparator 
conditions, were found in seven studies. No evidence of superiority for the 
positive CBM-I intervention in affecting cognitive bias was found in three 
studies, including the most rigorously implemented study (1).  
Improved cognitive bias was found on all implemented outcome measures 
for three studies. This included the study in which the outcome stimuli were 
identical to the CBM-I training stimuli (6); therefore generalizability of this finding 
to other ambiguous situations is uncertain. The adjusted mean difference was 
2.72 for shift in bias on a scale from 1 to 15 on an emotion recognition task. The 
short multi-paradigm study (3) showed a 0.13 difference on a 0 to 1.0 scale for 
SST between groups, d = 0.60, and a 8.23 difference on a 6 to 42 scale for 
RIQ, d = 1.34. One study (7) found superiority in increasing positive bias for the 
positive CBM-I group over the negative CBM-I group (a 6.09 difference on a 0 
to 100 scale for a homophone task, d = 0.56) but not the mixed CBM-I group. 
Mixed findings occurred in some studies. One study (8) found improved 
cognitive bias for the positive CBM-I group using imagery, post-intervention (a 
28.43 difference compared with the imagery group on a 0 to 100 scale for SST, 
d = 0.77, and 24.99 compared with the control group, d = 0.73) however, at 
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follow-up, the non-imagery positive CBM-I group showed increased negative 
bias (a difference of 42.17, d = 2.32). Another study (9) found increased positive 
bias on the Ambiguous Scenarios Test for Depression (Berna, Lang, Goodwin & 
Holmes, 2011; a 0.77 difference on an unspecified scale, corresponding to a 
medium effect size) but no SST difference. The study identified the majority of 
included measures as primary outcomes but proposed no explanation for why 
improvements were found on some measures and not others. The case-series 
study (2) showed improved cognitive bias for four of seven participants. 
Association between change in bias and mood. 
The relationship between change in bias and mood was examined by five 
studies (1, 3, 5, 8, & 9); all found a positive association. The importance of this 
analysis is to investigate the hypothesised mechanism of CBM treatments on 
mental health symptoms, i.e., change in cognitive bias is hypothesised to 
mediate changes in mood. These associations are not necessarily causative.  
Review Findings 
The objective of this review was to examine the effectiveness of CBM-I on 
depressive symptoms. Theoretical underpinnings of the effect of CBM-I on 
depression suggest changes in interpretation bias can mediate changes in 
mood symptoms. Ten studies were systematically selected. All investigated use 
of a positive CBM-I paradigm with participants experiencing depression or 
dysphoria. The main findings showed a mixed picture: inconsistent evidence of 
improvement on a variety of relevant outcomes measuring depressive 
symptoms and interpretation bias, compared to various control conditions. 
Significant differences between groups were generally medium sized effects; 
the clinical significance of these differences is unclear because minimal 
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clinically important differences were not routinely reported. The mixed picture of 
findings falls between the negative and optimistic results of the two meta-
analyses: no evidence that CBM modifies depression (Hallion & Ruscio, 2011); 
positive or benign CBM-I paradigms are associated with increased positive 
interpretations and decreased negative mood states (Menne-Lothmann et al., 
2014). Inconsistent findings could relate to issues regarding the underlying 
theory, implemented interventions, or study methodology. CBM-I might not be 
an effective treatment for depression; not all CBM-I paradigms might be 
effective in affecting changes in cognitive bias to mediate changes in mood; 
limitations in study methodology might have prevented significant positive 
effects from being found. 
Study designs showed different levels of quality. The most rigorous study 
(1), which incorporated a multi-session, multi-paradigm CBM-I intervention, with 
the biggest sample, and longest follow-up, found no evidence to support 
hypotheses of reductions in symptoms of depression and negative bias. 
Subgroups of responders, moderating factors, and improvements in specific 
depressive symptoms were identified: participants with less than five episodes 
of depression, vividly imagining scenarios from a field perspective, and 
anhedonia. Existing treatments for depression are not effective for everyone 
(Hollon, Stewart, & Strunk, 2006) so CBM-I could be a viable intervention even 
if it is only effective for certain groups. 
Limitations 
Ten studies with heterogeneous designs were reviewed. This small, varied 
sample reduces the external validity of the findings. A thorough search for 
relevant papers was implemented but there is a risk of publication bias 
concealing further null findings. Many outcome measures were included in 
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studies, increasing the risk of a Type I error. Studies with small samples were 
underpowered to detect small significant effects (all reported significant effects 
were more than Cohen’s d = 0.5). The study with the biggest sample (1; n=150) 
suggested it was still underpowered to detect small effects; the significant 
change for anhedonia was only a small to medium effect size. CBM researchers 
have suggested that even if CBM-I interventions produce a change in outcome 
measure corresponding to a small effect size it would be worth further 
investigation into CBM-I as a depression treatment because of its low-intensity, 
cost-effective nature (Blackwell et al., 2014). If a CBM-I intervention were found 
to lead consistently to improvements corresponding to a small effect size, 
however, patients and health professionals might be overoptimistic about its 
potential, which could lead to frustration and further depression.  
Recommendations 
Identification of the most effective CBM-I paradigm, and the most 
meaningful, sensitive measures is important in the development of finding an 
effective CBM-I treatment for depression. An important goal to pursue is 
clinically significant change rather than small effect sizes. Further investigation 
into what constitutes minimal clinically important differences on outcome 
measures used in CBM-I research would be beneficial. An additional 
consideration is its potential to be an accessible adjunct to other interventions, 
whether or not it brings about clinically significant change on its own. Studies 
should ensure rigor in design, implementation, and reporting; the CONSORT 
checklist (Schulz et al., 2010) is a helpful tool to follow. When designing 
interventions and comparators, ethical implications should be considered. 
Analysis of the underlying mechanism of the intervention, using mediation 
analysis, is important for inclusion in future studies. Some studies included 
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measures of acceptability, which should be routinely used to ensure any 
treatment developed is acceptable. Only one study was implemented in a 
country where English is not the first language, translating the intervention into 
Persian (8). The verbal nature of three CBM-I paradigms reduces accessibility 
for many people, worldwide. Only one study tested the face-morph paradigm 
(6), which could be adapted to be non-verbal. Further investigation of the 
effectiveness of non-verbal CBM-I tasks is a recommendation for developing 
more accessible interventions. 
Conclusion 
This systematic review has examined ten studies that have used CBM-I 
interventions with people with depression and dysphoria to investigate its effect 
on depressive symptoms. The findings were mixed, suggesting the intervention 
is not currently at a stage to be recommended as a treatment possibility for 
depression. Identification of the most meaningful outcome measures and 
effective CBM-I paradigm, perhaps a non-verbal design to maximise 
accessibility, paired with further rigorous studies are recommendations for 
further research in this field.  
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Abstract 
Depression is a global problem, causing disability and economic burden. Many 
people currently do not obtain treatment. Development of more accessible, 
cost-effective treatments is essential. An identified mechanism by which 
depression treatments work is through modifying underlying negative cognitive 
biases, which mediate changes in mood. A specific negative information-
processing bias in depression is a tendency to interpret ambiguous facial 
expressions as sad rather than happy. The emotion recognition task is a 
treatment paradigm developed as a cognitive bias modification intervention to 
target this emotion recognition bias. Previous studies showed promising signs 
that this novel intervention could modify biases in people with low mood outside 
of laboratory conditions and potential to increase positive affect within 
laboratory conditions. The current study built on these developments, aiming to 
investigate, using a randomised controlled trial with follow-up at 2 and 6 weeks, 
whether a web-based version of the emotion recognition task could reduce 
depressive symptoms in addition to modifying emotion recognition biases. An 
analogue sample of 124 participants with low mood was recruited. Evidence 
was found that the intervention modified participants’ biases, compared to the 
control group but there was no evidence of improvement in mood. Study 
limitations included a high rate of attrition and non-adherence to the 
intervention. Future recommendations include modifying the intervention to 
increase acceptability, investigating generalizability of increased positive bias to 
different stimuli, and identifying consistent reductions in symptoms of 
depression before examining its efficacy with a clinical population. 
EFFECTS OF CBM-I ON DEPRESSION 
50 
Introduction 
Depression is a major cause of disability (Rodgers et al., 2012) 
characterised by persistent low mood and loss of interest in activities, 
accompanied by changes in psychomotor activity, sleep, and appetite, lack of 
energy, feelings of worthlessness, concentration difficulties, and suicidal 
ideation (American Psychiatric Association, 2000). Evidence-based treatments, 
such as cognitive-behavioural therapy (CBT), are often delivered face-to-face. 
This makes them inaccessible for many people, particularly when depression is 
becoming more prevalent (Ustun, Ayuso-Mateos, Chatterji, Mathers, & Murray, 
2004) and there is increasing pressure on healthcare budgets. Innovative, 
accessible, automated treatments could allow more people to receive help. This 
study investigated the potential of a web-based programme aimed at modifying 
emotion recognition biases to reduce depressive symptoms. This section will 
outline the rationale for this study, first describing cognitive theories of 
depression with emphasis on negative biases, then cognitive treatments with a 
focus on cognitive bias modification (CBM). 
Cognitive Models of Depression 
Cognitive perspectives of how psychological problems develop generally 
emphasise the role of interpreting ambiguous situations with a negative bias 
(Hughes, Panzarella, Alloy, & Abramson, 2007). Interpretation of stimuli and 
other cognitive processes are hypothesised to be underpinned by schemata, 
composed of core beliefs: how we see ourselves, others, the world, and future 
(Beck, 1976). These schemata assist us in processing complex information, 
biasing how we attend to, interpret, and remember information. Low mood is 
hypothesised to be maintained by negative internal representations of the world 
and associated negative information-processing biases: overgeneralising and 
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assuming personal responsibility for negative events, and disqualifying or 
ignoring positive information. A subtly different theory, depressive realism, 
suggests people with depression might perceive situations more accurately than 
people without depression who have optimistic biases (Alloy & Abramson, 
1988); both theories emphasise people with depression have a more negative 
cognitive style than those without depression. It should be noted that other 
cognitive theories of depression, not discussed here, emphasise processes 
other than negative biases, including rumination (e.g., Nolen-Hoeksema, 1991) 
and executive control (e.g., Dalgleish et al., 2007). 
Beck’s model of depression, which focuses on negative schema and 
negative biases, led to the development of CBT, a recommended evidence-
based treatment for depression (National Institute for Health and Clinical 
Excellence, 2009). The cognitive component of CBT targets modification of 
negative automatic thoughts regarding self, others, the world and future (Beck, 
Rush, Shaw, & Emery, 1979). The inaccessibility of face-to-face therapy has 
been partly addressed through the development of computerised CBT (cCBT; 
e.g., Andersson et al., 2005). 
CBM Research for Depression 
Unlike cCBT, which was designed to replicate traditional CBT, CBM 
treatments have been developed from experimental research and informed by 
cognitive science, fitting with an ‘experimental medicine’ framework (Lang, 
Blackwell, Harmer, Davison, & Holmes, 2012). Evidence was found showing 
people with depression have negative information-processing biases, including 
interpreting (Rude, Wenzlaff, Gibbs, Vane, & Whitney, 2002), attending to 
(Joorman & Gotlib, 2007), and remembering information (Mathews & MacLeod, 
2005). CBM studies developed from theory-testing paradigms to investigating 
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the effectiveness of CBM as an intervention, targeting negative biases occurring 
at different levels of cognitive processing, interpretation (Blackwell & Holmes, 
2010), attention (Baert, De Raedt, Schacht, & Koster, 2010) and memory 
(Joormann, Hertel, LeMoult, & Gotlib, 2009), with the aim of mediating changes 
in mood. 
Antidepressant Treatment and CBM 
A neurocognitive model of the action of antidepressant medication shows 
similarities to the underlying mechanism proposed for CBT and CBM. At a 
neuropsychological level, emotional and social stimuli have been found to be 
processed in a more positive manner quickly after drug administration (Harmer, 
Goodwin, & Cowen, 2009). Change in bias is hypothesised to lead to gradual 
changes in social interactions, followed by improved mood; establishing a self-
sustaining virtuous cycle. Compared with people without depression, people 
with depression generally interpret ambiguous facial expressions as less happy 
(Bourke, Douglas, & Porter, 2010). This negative bias was found to decrease 
after a single dose of antidepressants (Harmer et al., 2009) and before 
subjective changes in mood occur (Tranter et al., 2009). This evidence supports 
the view that cognitive models of depression, which emphasise the importance 
of negative biases, fit with the proposed action of antidepressants (Harmer et 
al., 2009). Therefore, antidepressants, CBT, and CBM might employ similar 
mechanisms in treating depression, i.e., reducing negative biases to mediate 
improvements in mood. Regarding antidepressant treatment, many people 
prefer to avoid taking medication; this underlines the importance of pursuing 
innovative, non-invasive, cognitive interventions that modify cognitive biases 
and treat depression. 
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CBM for Emotion Recognition 
A CBM paradigm was developed to directly target emotion recognition 
biases (Penton-Voak, Bate, Lewis, & Munafò, 2012), similar to biases found to 
be modulated by antidepressants, described above. This CBM task, described 
as the emotion recognition task (ERT) in this report, aims to reduce negative 
biases and promote positive biases when interpreting ambiguous facial 
expressions. For example, the program can reinforce the identification of 
ambiguous faces as showing a happy, rather than sad, emotion. The rationale 
for using facial expressions as a target for interpretation modification to treat 
depression stems from findings that people with depression, when compared 
with healthy controls, have a negative bias towards interpreting ambiguous or 
neutral faces as sad or less happy (Bourke et al., 2010). A negative bias 
towards interpreting ambiguous faces can maintain depressive schemas about 
others and the world because people with depression interpret their 
environments as having more sadness and negativity than people without 
depression. Promotion of a more positive bias to emotion recognition could 
reduce negative interpretations that are maintaining depressive schemas about 
the world, which could mediate a reduction in depressive symptoms.  
There have been promising preliminary results in modifying emotion 
recognition biases, which could provide therapeutic benefit for people with 
depressive symptoms (Penton-Voak et al., 2012). The hypothesis for the action 
of the ERT matches the model of the action of antidepressants (Harmer et al., 
2009): early changes occur in decreasing negative biases; this is predicted to 
gradually have a positive impact on social interactions, eventually causing 
positive changes in subjective mood. Preliminary findings showed the ERT, 
which promotes the identification of positive over negative emotion, might have 
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beneficial effects on mood, which persist for at least two weeks (Penton-Voak et 
al., 2012). The results were generated in a laboratory setting with adults 
recruited from the general population on the basis of having at least a mild level 
of depression, as indicated by a score of 14 or more on the Beck Depression 
Inventory-II (BDI-II; Beck, Steer, & Brown, 1996). Studies investigating the 
generalizability of the ERT have shown good potential for reducing problematic 
behaviours in young offenders (Penton-Voak et al., 2013) and effectiveness in 
modifying emotion recognition biases of people with low mood via portable 
devices (e.g., smartphones and tablets) outside of laboratory conditions (Brazil, 
Munafò, & Penton-Voak, 2012). 
Penton-Voak and colleagues (2012) recruited 80 participants with low 
mood for their laboratory-based study. Participants were divided randomly into 
two groups: one received the ERT; the other, sham-ERT. There was limited 
attrition: two participants discontinued the intervention and one did not complete 
the follow-up stage. Issues of attrition are important to consider for measuring 
the acceptability of the intervention, particularly if it is to be developed as an 
accessible treatment. Following training, the threshold for identifying ambiguous 
faces as happy rather than sad was significantly different between groups: the 
training group had a more positive bias than the control group. Positive affect, 
measured by the Positive and Negative Affect Schedule (PANAS; Watson, 
Clark, & Tellegen, 1988), showed a significant increase for the training group 
compared with the control group. Reductions in low mood, measured by the 
BDI-II, which was the primary outcome measure, and negative affect, measured 
by the PANAS, were statistically non-significant between the groups. Penton-
Voak and colleagues (2012) noted study limitations including lack of statistical 
power to detect what they described as “modest (but clinically valuable) 
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improvements in mood” (p. 72). The study’s sample size (n = 77) provided 80 
percent power to detect, at an alpha level of 0.05, a difference of six points on 
the BDI-II (assuming SD = 10) and five points on the PANAS (SD = 7); the 
minimal clinically important difference was not defined. Additionally, follow-up 
was 2 weeks post-training and the researchers suggested that assessing mood 
change over a longer period would be valuable. The current study aimed to take 
into account these limitations, recruiting a larger sample and assessing mood 
change both 2 and 6 weeks after training ended. 
Brazil and colleagues (2012) demonstrated that the ERT could be 
effective in modifying cognitive biases outside laboratory conditions when 
accessed using portable devices such as smartphones. They recruited 88 
participants with low mood, defined by a score of 14 or more on the BDI-II. 
Attrition was 20%: four participants dropped out before the end of the study; 
technical problems caused 14 participants’ data not to be collected. The ERT 
was installed onto participants’ smartphones and tablet computers for 
independent use over 6 weeks: on average participants chose to use the 
program on five occasions. The magnitude of the shift in bias for identifying 
ambiguous faces as happy rather than sad increased with the number of 
training sessions completed. 
Aim of Study and Hypotheses 
The aim of the present study was to extend previous research (Brazil et 
al., 2012; Penton-Voak et al., 2012) by investigating whether the ERT showed 
signs of therapeutic benefit on low mood when accessed through the internet, 
outside of laboratory conditions. The main objective was to investigate whether 
participants experienced a therapeutic benefit on mood measured by the BDI-II, 
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in addition to a shift in bias for identifying ambiguous faces as happy rather than 
sad, compared with a control group assigned to a sham-ERT. 
The primary hypothesis predicted that (a) participants who accessed the 
ERT would have fewer symptoms of depression as measured by the BDI-II, at 6 
weeks follow-up, than those randomised to the control group. Secondary 
hypotheses were (b) participants in the training condition would have fewer 
symptoms of depression at two other time-points, post-intervention and 2 weeks 
follow-up, as measured by the BDI-II, than the control group. Also, (c) 
participants in the training group would have less negative mood, and more 
positive mood as measured by the PANAS, at three time-points, post-
intervention, 2 and 6 weeks follow-up, than the control group. It was further 
hypothesised that (d) participants in the training group would have a more 
positive bias for interpreting ambiguous facial expressions as happy than sad, 
as measured by the thresholds obtained at time-points after baseline, compared 
to the control group. This was a manipulation check to ensure the intervention 
was having an effect; furthermore, this analysis was used to check that previous 
work was replicable by this study.  
Exploratory analyses were carried out to find whether (a) participants 
randomised to the training group had fewer symptoms of anxiety, measured by 
the Beck Anxiety Inventory (BAI; Beck & Steer, 1993), than the control group. 
The majority of previous CBM intervention studies have investigated 
effectiveness in reducing anxiety symptoms (Torkan et al., 2014). Further 
exploratory analyses examined the moderating effects of (b) baseline 
depression and (c) baseline anxiety on how use of the ERT affected BDI-II 
outcomes. The intervention might vary in its effectiveness for people with 
different baseline levels of anxiety and depression. Indeed, Blackwell and 
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colleagues (2014) found bigger improvements in BDI-II outcomes, after 
participation in a CBM intervention, for people with fewer previous episodes of 
depression. Additional exploratory analyses examined similarities between the 
effect of the ERT and Harmer and colleagues’ (2009) model of the mechanism 
of antidepressant drugs. This was investigated by finding whether early 
changes in cognitive bias, as measured by the difference between participants’ 
first and last observed ERT thresholds, predicted later mood, as measured by 
the BDI-II and PANAS. Finally, exploratory analyses were undertaken to 
investigate the acceptability of the training program; all participants were asked 
to complete an acceptability measure, post-training. Adherence to the protocol 
and attrition were also analysed.  
Method 
Design 
A randomised controlled study design was used. Participants were 
randomised to receive the ERT or a sham-ERT, which did not aim to modify 
participants’ interpretations of facial expressions. Participants were blind to 
whether they were randomised to the control or treatment group. The 
researcher was blind to the assignment of participants to groups until email 
reminders to complete further sessions of training were required to be sent out.  
Participants 
Adults from the general population contacted the researcher between 
August 2013 and February 2014 to register their interest in the study (N = 627). 
Due to time constraints no more participants were registered after this date. 
Opportunistic sampling was employed by advertising in a variety of places 
including social media, mental health forums, universities, newsletters for NHS 
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and local council staff, libraries, churches, cafes, pubs, and shops. The 
screening survey, run through Bristol Online Surveys (BOS) was completed by 
428 people. Of these, 124 (83.2% female) met the inclusion criteria and 
consented to take part in the study. To be eligible, participants had to score 14 
or more on the BDI-II and indicate they were over 18, had normal or corrected 
vision, were not using illicit drugs (other than cannabis), were not receiving 
psychiatric medication or psychotherapy, did not have a diagnosed psychiatric 
disorder (other than depression), major illness, head injury or intellectual 
disability. These eligibility criteria were chosen to match previous low mood 
research using the ERT (Penton-Voak et al., 2012; Brazil et al., 2012), and 
other planned trials (Adams, Penton-Voak, Harmer, Holmes, & Munafò, 2013), 
enabling helpful comparisons between studies. All contact between the 
researcher and participants was carried out via the internet. Despite an 
international recruitment strategy, via social media and mental health forums, 
ninety-six percent of the randomised participants (n = 119) stated they lived in 
the UK; one participant lived in Greece, one in Ireland, another in the United 
Arab Emirates, and two in the USA. All participants declared they had a good 
command of the English language. Participants were aged 18 to 71 years (Mdn 
= 41.00). Additional socio-demographic information, e.g., ethnicity, level of 
education, and social economic status were not collected. Participants were 
offered a chance to participate in a raffle to win gift vouchers between the value 
of £10 and £50, as compensation for taking part. The study received ethics 
approval from the University of Exeter and was conducted according to Good 
Clinical Practice guidelines. 
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Materials 
CBM emotion recognition task (ERT). 
The ERT involved participants being shown sequences of faces, which 
morphed from happiness to sadness. Variations of this design have been used 
in similar studies (Brazil et al., 2012; Penton-Voak et al., 2012). Prototypical 
“happy” and “sad” composite images were generated from 20 individual male 
faces showing a sad facial expression and the same 20 individuals showing a 
happy expression using established techniques (Tiddeman, Burt, & Perrett, 
2001). Original images came from the Karolinska Directed Emotional Faces 
(Lundqvist, Flykt, & Öhman., 1998). These prototypical images were used as 
endpoints to generate a linear morph sequence, consisting of images that 
changed incrementally from unambiguously “sad” to unambiguously “happy” 
with emotionally ambiguous images in the middle. Figure 1 shows an example 
morph sequence with unambiguous sad and happy endpoints and intermediate 
stimuli. 
Initially, the threshold for detecting one emotion over another in an 
ambiguous expression (i.e., a blend of happiness and sadness) was assessed; 
individuals then received feedback to modify this threshold (i.e., to favour the 
identification of happiness over sadness). On each of the five occasions that 
participants were asked to use the web-based programme for training it 
consisted of three phases: (1) baseline, (2) training, and (3) test.  
The baseline and test phase each consisted of 45 trials in which each 
stimulus from the morph sequence was presented to the participant three times. 
Exemplar faces were from a 15-frame continuum, morphing from happy to sad. 
Participants’ judgments as to whether presented faces were happy or sad were 
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obtained using a two-alternative forced choice procedure. Images were 
presented one at a time, in random order for 150 ms. Stimuli were preceded by 
a fixation cross which was presented for a random period ranging from 1500 to 
2500 ms. Subsequent to presentation, and to prevent processing of 
afterimages, a backward mask of noise was presented for 250 ms, followed by 
a prompt asking the participant to judge whether the face presented had been 
happy or sad. This remained onscreen until the participant made a response.  
Each trial in the training phase was similar to baseline and test phase 
trials with respect to inter-trial interval and stimulus presentation, but with the 
addition of feedback subsequent to the participant’s response. In the control 
condition, the sham-ERT was programmed to give feedback based on 
participants’ baseline thresholds. Original thresholds could vary from 1, 
indicating all faces were being interpreted as sad, to 15, indicating all faces 
were being interpreted as happy; the mid-point threshold was 8. The average 
baseline ERT threshold in a laboratory setting has been reported as 6 for 
people with low mood and 7 for a healthy control group, indicating those with 
low mood had significantly more negative bias than those without dysphoria 
(Penton-Voak et al., 2012). When the ERT was presented via smartphones, the 
average baseline threshold of people with low mood was 8, i.e., the mid-point 
(Brazil et al., 2012). The sham-ERT classified responses as “correct” if the 
participant identified images below the original threshold as sad and above it as 
happy; any deviation from baseline thresholds was classified as “incorrect”. 
Feedback was a message saying “Correct/Incorrect! That face was sad/happy.” 
In the active intervention condition, the ERT also gave feedback based on 
participants’ baseline thresholds; however, the ERT was programmed to shift 
the “correct” classification two steps towards the sad end of the continuum (also 
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illustrated in Figure 1). Hence, the two images nearest the baseline threshold, 
which participants would previously have classified as sad at baseline, were 
classified as happy when providing feedback. Six training blocks, consisting of 
randomised sequences of 31 faces, were given to each participant, resulting in 
186 training trials in total. In each training block, participants were shown more 
images close to their baseline thresholds rather than the extreme ends of the 
continuum.  
 
 
Figure 1. Sample of a face morph sequence: Unambiguous sad and happy 
endpoints and intermediate stimuli are highlighted; the shift in classification of 
ambiguous faces as happy rather than sad is also illustrated. From Penton-
Voak et al., (2012). 
 
Mood assessments. 
Three measures of mood were used: the BDI-II, mood rated over the 
past week; PANAS, mood rated over the past day; and BAI, mood rated over 
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the past month. These assessments were used at baseline, and three follow-up 
times: post-training, 2 weeks, and 6 weeks later. These mood assessments 
have been used in other studies (Adams et al., 2013; Penton-Voak et al., 2012), 
which have investigated the ERT with people with dysphoria, enabling results to 
be more easily compared across studies. The BAI, BDI-II, and PANAS have 
been found to retain their psychometric properties when used via the internet 
(Carlbring et al., 2007; Holländare, Andersson, & Engström, 2010; Howell, 
Rodzon, Kurai, & Sanchez, 2010). 
The BDI-II was used to obtain data relating to the severity of participants’ 
depression symptoms. It is a widely used self-report scale (Holländare et al., 
2010), composed of 21 questions. Each item yields a score between 0 and 3; 
total scores range between 0 and 63. Higher scores are associated with higher 
levels of depressive symptoms. According to the BDI-II manual (Beck et al., 
1996), scores of 0 to 13 indicate minimal depression, 14 to 19 mild depression, 
20 to 28 moderate depression, and 29 to 63 severe depression. Internal 
consistency for baseline BDI-II scores of participants in the present study was 
good (α = .78). One week test-retest reliability has been reported to be excellent 
(r = .93; Beck et al., 1996). Content validity has been described as excellent 
and construct validity is well supported (Dozois & Covin, 2004).  
The PANAS obtained data relating to positive and negative affect. 
Positive affect is the extent to which people feel enthusiastic, alert, active, and 
appreciative. Negative affect is an orthogonal concept, relating to subjective 
distress, discontentment, and aversive mood states including anger, guilt, 
contempt, and fear. Low levels of positive affect indicate sadness and lethargy; 
whereas, low levels of negative affect indicate serenity and calmness (Watson 
et al., 1988). The positive subscale is negatively correlated with measures of 
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depression; the negative subscale positively correlated. Both subscales have 
explained a significant proportion unique to depression, positive affect 
significantly more (Crawford & Henry, 2004). The PANAS is a 20-item self-
report measure, ten relate to positive mood and ten to negative mood. 
Participants rated, on a scale from one to five, the extent to which they had 
experienced certain emotional states over the past day. Total scores for the 
subscales range from 10 to 50; higher scores are associated with a higher level 
of affect. Internal consistency for baseline PANAS positive and negative 
subscale scores of participants in the present study was good (α = .88 for both 
subscales). Eight-week test-retest reliability, relating to responses for the past 
week, has revealed a coefficient of .47 for both subscales; good levels of 
construct validity have also been reported (Watson et al., 1988).  
The BAI is a 21-item self-report scale, used to measure severity of 
anxiety. It was developed to have discriminant validity from depression 
measures (Beck, Epstein, Brown, & Steer, 1988). Respondents rate on a scale 
from zero to three the extent to which they have experienced symptoms of 
anxiety over a given period. Total scores range from 0 to 63; higher scores are 
associated with higher levels of anxiety. Internal consistency for baseline BAI 
scores of participants in the present study was good (α = .87). A high level of 
test-retest reliability has been described (r = .75; Beck & Steer, 1993). 
Procedures 
Adults were recruited from the general population via advertisements, 
which directed them to email the researcher. They were given unique 
usernames to access a screening survey, which was created using BOS. 
Participants responded to questions relating to consent, inclusion criteria, and 
demographic data. Baseline mood was assessed at this stage using the BDI-II, 
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PANAS, and BAI. The researcher checked participants’ responses and sent 
debriefing information to those who did not meet the inclusion criteria. Those 
who met the criteria were emailed instructions for using the ERT. Each eligible 
participant was registered onto the program’s system; this generated an 
automatic email, which requested that the program was activated within 7 days. 
On activation, participants were randomly assigned by the program to the 
treatment or control group; thus treatment allocation was concealed at this 
stage. Emails were sent by the researcher to remind participants to activate the 
program; participants were re-registered if they had not activated the program 
within the allocated time. Participants were sent a reminder email if they 
appeared not to be completing the training on 5 days close together, 
specifically, if there was a gap of 5 days between sessions. Participants were 
asked to access a post-intervention survey, to complete the BDI-II, PANAS, 
BAI, and an acceptability measure used by Adams and colleagues (2013; 
Appendix A), following participants’ fifth use of the ERT, or on a day close to 
when they were predicted to have accessed the fifth session if training was not 
completed. Emails were sent 2 and 6 weeks later, asking participants to access 
follow-up surveys consisting of BDI-II, PANAS, and BAI questionnaires. 
Debriefing information was emailed to each participant following data collection. 
Analyses 
Sample size and power calculations. 
 A sample size of N = 164 was required to detect, with 80% power at an 
alpha level of 5%, a decrease in the primary outcome measure, BDI-II, of the 
magnitude found by Penton-Voak and colleagues (2012). Their study showed 
the mean of participants’ baseline BDI-II scores was 23.05 (s.d. 8.9); following 
ERT the mean score for the treatment group was 19.3 (s.d. 10.2); on this basis 
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the effect size was d = 0.39. Penton-Voak and colleagues (2012) randomised 
80 participants who met similar criteria to the current study after screening 193 
people. Based on this information, the current study aimed to screen at least 
396 people; 435 people were screened but this only led to 124 participants 
being randomised. High rates of attrition led to 87 participants’ data being 
analysed at 6 weeks follow-up. This sample size (N = 87) provided 80% power, 
at an alpha level of 5%, to detect a difference of 5.37 points on the BDI-II 
(assuming s.d. 10) and 3.76 points on the PANAS (assuming s.d. 7). 
Linear regression analyses. 
Data were analysed using SPSS for Windows, Version 21. Intention-to-
treat (ITT) analyses were used, whereby all data from each randomised 
participant were used. A limitation of the ITT analyses was that only a small 
proportion of randomised participants completed all five days of the ERT. If 
participants who do not receive treatment are included in the analysis as 
participants who did receive treatment, the effect of the treatment is diluted and 
the analysis is a more conservative estimate, leading to more Type I errors 
(Gupta, 2011). Therefore, exploratory per-protocol analyses were also carried 
out. For these linear regressions, only participants who had completed the ERT 
on at least two occasions (Training group: N = 33; Control group: N = 34) were 
included. 
A hierarchical regression model was used to examine the primary 
hypothesis (a) and secondary hypotheses (b) and (c). Methods of data cleaning 
are described in Appendix B. Appendix C summarises the outcome measures, 
predictors, and order of entry for each hierarchical regression model. For 
example, to analyse the primary hypothesis (a), the outcome measure was BDI-
II at 6 weeks, the predictors were entered in the following order: baseline BDI-II, 
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followed by the categorical predictor, i.e., training group (1), control group (0). 
Exploratory analysis of whether baseline depression was a moderator of BDI-II 
at 6 weeks followed the above description with an additional predictor, i.e., the 
product of baseline BDI-II score and group. This third predictor was entered 
last. Subsequent predictors were included even if zero-order correlations were 
not significant. 
Exploratory analyses were carried out using hierarchical linear 
regression. These analyses included testing whether participants randomised to 
the training group had fewer symptoms of anxiety, measured by the BAI, than 
the control group, and examining the moderating effects of baseline depression 
and baseline anxiety on how use of the ERT affected BDI-II outcomes. 
Similarities between the effect of the ERT and Harmer and colleagues’ (2009) 
model of the mechanism of antidepressant drugs were examined by carrying 
out further exploratory analyses. These investigated whether early changes in 
cognitive bias, as measured by the difference between participants’ first and last 
observed ERT thresholds, predicted later mood. 
ERT threshold manipulation check. 
To check hypothesis (d), a graph was used to plot the mean ERT 
thresholds and 95% confidence intervals for the training and control group at 
each time-point. As this showed non-overlapping confidence intervals at all 
time-points other than the first, carrying out linear regression analyses was 
unnecessary.  
Acceptability questionnaire analysis. 
The findings from the acceptability questionnaire were summarised in 
Table 6. Comments made by participants were examined using content analysis 
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(Berg, 2001). Familiarisation with the data was ensured; this was followed by 
fitting data to a coding framework as to whether or not participants suggested 
the task had been or become (a) too long (b) unenjoyable, (c) unengaging, (d) 
associated with challenges (e) associated with a positive change in mood, and 
(f) associated with a negative change in mood. The number of participants in 
each group who had made comments relating to each of these categories was 
summed. Chi-squared comparisons were made to analyse whether there were 
differences between responses for the training and control groups.  
Categorical data, as to whether participants suggested they would 
access the program again, would recommend it to a friend, and rated the task 
instructions as easy to understand, were examined using chi-squared 
comparisons to compare differences between the control and training group.  
Themes relating to specific challenges participants had commented on 
and ideas for improving the task’s accessibility were identified using a thematic 
analysis, based on a method described by Braun and Clarke (2006). Data 
familiarisation was ensured, followed by generation of initial codes. Finally, 
themes relating to challenges and ideas for task improvement were searched 
for, reviewed, and named.  
Results 
Demographic Characteristics 
Table 1 shows demographic data regarding age, gender, and country of 
residence of participants who were randomised into the main study. The flow of 
participants in the study is shown in the CONSORT diagram (Figure 2). Table 2 
summarises mood scores and cognitive bias, measured by ERT threshold, at 
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each time-point for the control and training group; correlations between 
outcome measures are included in Appendix D. 
Table 1 
Demographic data of randomised participants 
 Training group (N = 66) Control group (N = 58) 
Age 19 to 71 (median = 42.50) 18 to 69 (median = 39.00) 
Female 79% (n = 52) 88% (n = 51) 
Non-UK residents 3% (Greece, n = 1; United 
Arab Emirates, n = 1) 
5% (Ireland, n = 1; United 
States of America, n = 2) 
  
EFFECTS OF CBM-I ON DEPRESSION 
69 
 
  
   Did not meet inclusion criteria (N= 297) 
   No further contact (N= 14) 
Analysed for primary hypothesis, 
intention-to-treat with last observation 
carried forward for missing data (N= 66) 
 
Allocated to training group (N= 66) 
 Participated in allocated intervention: 5 full 
sessions (N= 12) 
Partially participated in training: <5 full 
sessions (N= 44) 
Completed baseline only (N= 2) 
 Unable to access intervention: technical 
problems (N= 8) 
Allocated to control group (N= 58) 
 Participated in allocated intervention: 5 full 
sessions (N= 20) 
 Partially participated in training: <5 full 
sessions (N= 29) 
 Unable to access intervention: technical 
problems (N= 9) 
 Analysed for primary hypothesis, 
intention-to-treat with last observation 
carried forward (N= 58) 
 
Intervention 
Analysis 
Randomised (N= 124) 
Screening 
Requested information (N= 627) 
Screened for eligibility (N= 435) 
   No further contact (N= 192) 
Completed post-training survey (N= 26) 
Did not complete post-training survey (N= 40) 
Completed 2-week follow-up survey (N= 37) 
Did not complete 2-week follow-up survey (N= 29) 
Completed 6-week follow-up survey (N= 44) 
Did not complete 6-week follow-up survey (N= 22) 
 
Lost to follow-up (give reasons) (n=  ) 
Discontinued intervention (give reasons) (n=  ) 
Completed post-training survey (N= 33) 
Did not complete post-training survey (N= 25) 
Completed 2-week follow-up survey (N= 28) 
Did not complete 2-week follow-up survey (N= 30) 
Completed 6-week follow-up survey (N= 43) 
Did not complete 6-week follow-up survey (N= 15) 
 
Follow-Up 
Figure 2. CONSORT Flow Diagram. 
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Table 2 
Outcome measures at baseline and follow-up points 
  Pre-intervention Post-intervention 2-week follow-up 6-week follow-up 
  M (SD) M (SD) M (SD) M (SD) 
BDI-II      
Training   21.74 (6.21) N = 66 18.50 (8.19) N = 26 21.16 (10.10) N = 37 18.70 (8.83) N = 44 
Control  23.21 (8.22) N = 58 21.18 (10.30) N = 33 19.11 (11.09) N = 28 18.33 (9.84) N = 43 
PANAS: Positive      
Training  19.06 (7.03) 22.54 (6.72) 19.78 (8.80) 21.00 (8.47) 
Control  19.78 (6.18) 20.00 (7.27) 20.36 (7.27) 18.42 (7.57) 
PANAS: Negative      
Training  18.50 (7.27) 18.38 (6.45) 19.95 (8.74) 17.43 (7.85) 
Control  19.00 (7.29) 17.15 (6.46) 16.82 (7.51) 17.26 (6.70) 
BAI:      
Training  18.23 (9.05) 15.85 (11.63) 18.32 (11.75) 16.09 (12.49) 
Control  16.72 (10.70) 14.03 (12.19) 12.54 (11.16) 14.56 (10.56) 
ERT: Threshold      
Training  8.48 (1.25) N = 58 11.50 (2.78) N = 12   
Control  8.24 (1.45) N = 49 8.63 (2.06) N = 19   
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Results of Hypothesis Testing: Effect of Training on Mood 
 Table 3 summarises whether the group to which participants were 
assigned (i.e., training or control group) predicted mood outcomes. There were 
missing data at each time-point, this was not statistically different between 
groups. Post-intervention there were missing data for 60.6% of the intervention 
group and 43.1% of the control group (Chi-square with Yates’ correction = 3.12, 
p = .077); at 2-weeks follow-up 43.9% of the intervention group and 51.7% of 
the control group (Chi-square with Yates’ correction = 0.47, p = .493); at 6-
weeks follow-up 33.3% for the intervention group and 25.9% of the control 
group (Chi-square with Yates’ correction = 0.51, p = .477). Further exploratory 
analyses were carried out to investigate whether data were missing 
systematically, i.e., differences between characteristics of participants who did 
and did not complete the questionnaires (Appendix E). One significant 
difference was found for the training group: participants who completed the 
questionnaires at 6-weeks follow-up were significantly older than those who did 
not complete the measures. Significant differences were found for the control 
group: participants who completed the questionnaires post-intervention and at 
2-weeks follow-up had significantly lower baseline ERT thresholds indicating a 
greater negative bias, than those who did not complete the training program, 
than those who did not complete the outcome measures.  
There is no consensus for how to treat missing data in ITT analyses and 
different definitions of ITT exist (Alshurafa et al., 2012): (a) ITT is violated if any 
missing data occur; (b) missing data should be handled in a specified manner, 
e.g., last observation carried forward; (c) ITT refers to analysis of all data from 
randomised participants irrespective of how missing data are handled. Two 
methods of ITT analysis were utilised, which match definitions (b) last 
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observation carried forward, i.e., all 124 randomised participants were analysed, 
and (c) no imputation of data, i.e., 87 participants were analysed at 6 weeks 
follow-up (i.e., all participants who completed the questionnaire at that time-
point), 65 at 2 weeks follow-up, and 59 post-intervention. Data were not imputed 
for the per-protocol analyses. 
 Similar results for both ITT analyses and per-protocol analyses were 
found. There was no statistical evidence to support the primary hypothesis (a) 
that BDI-II scores at 6 weeks follow-up were significantly lower for participants 
randomised to the intervention group than the control group. Furthermore, there 
was no statistical evidence supporting the secondary hypotheses (b) that BDI-II 
scores at 2 weeks follow-up and post-intervention were significantly lower for 
participants randomised to the intervention group than the control group. Finally, 
there was no evidence supporting the secondary hypotheses (c) that at 2 and 6 
weeks follow-up, and post-intervention, scores on the PANAS negative 
subscale were significantly lower but significantly higher on the positive 
subscale for participants randomised to the intervention group than the control 
group. Contrary to hypothesis (c), there was evidence that scores on the 
PANAS negative subscale were significantly higher at 2 weeks follow-up for the 
intervention group than the control group. 
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Table 3 
Linear regression analysis of whether training group vs.control group predicted mood outcome. 
Note. B = adjusted mean difference. A positive coefficient indicates a higher outcome score for the training group than the control  group. 
LOCF = last observation carried forward. Bold font indicates a significant effect at alpha level .05. 1 = (N = 87) at 6 weeks; (N = 65) at 2 
weeks; (N = 59) post-intervention. 2 = (N = ) at 6 weeks; (N = ) at 2 weeks; (N = ) post-intervention. 
  Intention to treat analysis: LOCF 
(N=124) 
Analysis of all participants: no 
imputation for missing data1 
Per protocol analysis2 
  B 95% CI p B 95% CI p B 95% CI p 
BDI-II 6-week follow-up 1.33 -1.14 to 3.81 .288 1.95 -1.38 to 5.28 .247 2.49 -1.53 to 6.50 .220 
 2-week follow-up 2.02 -0.37 to 4.40 .098 4.15 -0.07 to 8.37 .054 4.09 -1.05 to 9.23 .116 
 Post-intervention 0.32 -1.40 to 2.04 .713 -0.48 -3.97 to 3.01 .783 -1.20 -5.07 to 2.67 .537 
PANAS  6-week follow-up 1.86 -0.59 to 4.31 .135 2.32 -0.85 to 5.48 .149 2.75 -1.36 to 6.86 .186 
positive 2-week follow-up -0.24 -2.32 to 1.84 .818 -0.40 -4.08 to 3.28 .828 -1.03 -5.30 to 3.24 .630 
 Post-intervention 0.56 -1.19 to 2.30 .528 2.38 -1.02 to 5.77 .166 1.49 -2.27 to 5.25 .429 
PANAS  6-week follow-up 0.55 -1.24 to 2.33 .547 0.48 -1.83 to 2.73 .695 0.13 -2.56 to 2.81 .925 
negative 2-week follow-up 2.89 1.08 to 4.70 .002 3.81 0.65 to 6.98 .019 4.15 0.40 to 7.89 .031 
 Post-intervention 1.04 -0.50 to 2.57 .183 1.64 -1.29 to 4.57 .267 0.88 -2.46 to 4.21 .598 
BAI 6-week follow-up -0.54 -3.23 to 2.14 .689 -0.37 -4.03 to 3.29 .840 -0.49 -4.81 to 3.83 .822 
 2-week follow-up 0.67 -1.80 to 3.14 .594 2.17 -2.54 to 6.87 .361 1.37 -4.10 to 6.85 .616 
 Post-intervention .56 -1.20 to 2.32 .531 0.42 -3.31 to 4.14 .824 -0.17 -4.40 to 4.06 .936 
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Secondary Hypothesis (d): Manipulation Check 
Figure 3 illustrates the mean thresholds before and after training 
sessions on each of the five days, for the training and control groups; the non-
overlapping 95 percent confidence intervals demonstrate significant differences 
between groups (data presented are based on pairwise analysis; a listwise 
analysis showed similar results. More detailed information is included in 
Appendix E). The training group had significantly higher ERT thresholds than 
the control group, indicating a more positive bias, at each time-point, except 
baseline. The mean threshold at baseline was 8.48 (s.d. 1.25; n = 58) for the 
training group and 8.24 (s.d. 1.45; n = 49) for the control group, indicating a 
relatively positive bias compared with participants in the study by Penton-Voak 
et al., (2012) and a similar baseline threshold to participants in the study by 
Brazil and colleagues (2012). Figure 3 shows the control group’s mean 
threshold remained stable across time whereas the training group’s increased 
over two sessions (indicating increased positive bias) then plateaued. The 
mean threshold after the fifth session was 11.50 (s.d. 2.78; n = 12) for the 
training group and 8.63 (s.d. 2.06; n = 19) for the control group. (21 participants 
from the control group completed the fifth day of training but two of their final 
thresholds were not recorded due to technical issues). 
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Figure 3. Mean thresholds before and after training sessions on each of the five 
days, for the training and control groups. 
Use of the ERT 
Table 4 shows participants from the control group completed significantly 
more sessions than the training group. Significantly more participants from the 
control group completed five sessions, as per-protocol. There was no significant 
difference between how many participants from each group were initially able to 
access the ERT program. 
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Table 4 
Use of the ERT 
 Training group 
(N = 66) 
Control group 
(N = 58) 
 
Baseline ERT 
data obtained 
88% (N = 58)^ 84% (N = 49)^ Yates’ Chi-square = 0.08, 
p = .775 
Completed 5 
sessions: Per 
protocol 
N = 12 N = 21 Yates’ Chi-square = 
5.12, p = .024 
Number of 
sessions 
accessed 
Median = 2 Median = 4 Two-tailed independent-
samples Mann Whitney 
U test, p = .048 
Note. ^ = Attrition due to technical problems with ERT program. Bold font indicates 
significant effect at alpha level .05. 
Exploratory analyses were carried out to investigate whether there were 
differences between participants who completed five sessions of the training 
program compared with participants who did not complete the training (Table 5; 
non-parametric and parametric tests produced the same results as far as 
statistical significance was concerned, therefore, only parametric test statistics 
have been reported). One significant difference was found for the training 
group: participants who completed the training program had significantly higher 
baseline scores on the PANAS positive subscale than those who did not 
complete the training program. This might reflect that to engage with the ERT a 
certain baseline level of motivation and enthusiasm is required. One significant 
difference was found for the control group: participants who completed the 
training program had significantly lower baseline ERT thresholds indicating a 
greater negative bias, than those who did not complete the training program. 
When interpreting these levels of statistical significance it should be taken into 
account that a number of similar exploratory analyses were undertaken: the 
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chance of obtaining familywise errors was increased and Type 1 errors could 
have occurred. 
Acceptability Questionnaire 
Thirty-nine percent (n = 26) of the training group and fifty-seven percent 
(n = 33) of the control group completed the acceptability questionnaire (Table 
6). Three of these participants indicated they had not been able to access the 
program (one training group and two control group participants). 
Categorical data. 
Most respondents agreed the task instructions were easy to follow. 
Around half of each group indicated they would use the task again and 
recommend it to a friend.  
Content and thematic analysis. 
Approximately seventy percent suggested the task was too long. Some 
participants suggested the length caused difficulty in concentration, and 
exacerbation of physical pain including repetitive strain injury, eyestrain, and 
headache. More than half the respondents from each group indicated they had 
not found the task enjoyable or engaging or had experienced a decrease in 
enjoyment and engagement through the task. Some participants suggested 
enjoyment and engagement could be increased by using expressions from 
many different people’s faces as stimuli. More than half the respondents from 
each group also reported experiencing challenging issues in completing the 
task. This included maintaining concentration, categorising ambiguous 
expressions, processing the images quickly, remembering and finding time to 
do the task, managing environmental distractions, and coping with feedback 
suggesting their judgment of emotions was incorrect. One fifth of respondents 
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from the training group noticed a negative change in mood, including anger, 
irritability, sadness, boredom, and guilt; whereas one fifth noticed a positive 
change, including feeling more relaxed, sociable, happy, and less grumpy. A 
smaller proportion of respondents from the control group noticed a change in 
mood. There was no significant difference between the responses of each 
group (when compared using a Yates’ chi-square analysis). 
Moderation of the Effects of Training on Depressive Symptoms 
Linear regression analyses of moderating effects of baseline measures 
are summarised in Table 7, without imputing data, and Table 8, imputing the 
last observation carried forward for missing data. When data were not imputed, 
baseline anxiety was a significant moderator of the effect of training on BDI-II 
score at 6 weeks follow-up; participants in the training group with lower baseline 
levels of anxiety experienced an improved effect from training on lowering BDI-II 
score, relative to the control group. This effect was not significant in the more 
conservative analysis when data were imputed. At the 5% level of probability, 
no other analyses showed evidence of a significant moderator.  
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Table 5 
A comparison of characteristics of participants who did and did not complete the training program 
Baseline measure Completed 5 sessions of training 
(Training: N = 12; Control: N = 21) 
Did not complete training 
(Training: N = 46; Control N = 28) 
  
  Mean (SD) Mean (SD) F p 
PANAS: Positive Training 24.08 (7.70) 18.15 (6.65) 4.26 .018 
 Control 18.05 (4.33) 20.21 (6.67) 1.78 .179 
PANAS: Negative Training 19.08 (6.79) 18.04 (7.42) 0.35 .703 
 Control 18.00 (6.84) 19.54 (8.12) 0.30 .739 
BDI-II Training 20.58 (9.18) 21.83 (5.32) 0.37 .692 
 Control 23.67 (7.00) 23.36 (9.19) 0.19 .827 
BAI Training 18.00 (7.63) 18.57 (9.36) 0.16 .855 
 Control 17.19 (11.02) 15.50 (11.07) 0.49 .618 
ERT Threshold Training 8.75 (1.22) 8.41 (1.26) 0.69 .409 
 Control 7.76 (0.94) 8.61 (1.66) 4.36 .042 
Age Training 42.42 (14.99) 41.33 (13.14) 0.08 .922 
 Control 41.14 (14.16) 39.64 (12.01) 0.43 .655 
Note. Bold font indicates significant effect at alpha level .05 
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Table 6 
Acceptability of the task 
 Training N=25 Control N=31 Yates’ Chi-square 
Found instructions easy 24 (96%) 29 (94%) 0.16, p = .685 
Would use the task again 15 (60%) 15 (48%) 0.36, p = .551 
Would recommend to a friend 10 (40%) 15 (48%) 0.13, p = .721 
Task too long 17 (68%) 22 (71%) 0.06, p = .810 
Task not engaging/ 
became less engaging 
13 (52%) 18 (58%) 0.03, p = .854 
Challenging issues 13 (52%) 18 (58%) 0.03, p = .854 
Task not enjoyable/ 
became less enjoyable 
16 (64%) 17 (55%) 0.18, p = .675 
Positive mood change 5 (20%) 5 (16%) <0.01, p = .980 
Negative mood change 5 (20%) 4 (13%) 0.13, p = .724 
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Table 7 
Linear regression of moderating effects of baseline measures 
 Moderation by baseline measure 
  Depression PANAS positive PANAS negative BAI 
BDI-II  B 95% CI p B 95% 
CI 
p B 95% CI p B 95% 
CI 
p 
 6-week 
follow-up 
-0.10 -0.54 to 
0.35 
.671 -0.20 -0.73 
to 0.33 
.462 -0.20 -0.73 
to 0.33 
.462 0.33 0.01 to 
0.66 
.046 
 2-week 
follow-up 
-0.34 -0.92 to 
0.24 
.247 -0.04 -0.72 
to 0.64 
.905 -0.01 -0.57 
to 0.58 
.980 0.23 -0.29 
to 0.74 
.389 
 Post-
intervention 
-0.13 -0.61 to 
0.35 
.581 -0.43 -1.00 
to 0.15 
.141 -0.11 -0.61 
to 0.39 
.652 0.12 -0.25 
to 0.50 
.514 
Note. Bold font indicates significant effect at alpha level .05. (N = 87) at 6 weeks, (N = 65) at 2 weeks; (N = 59) post-intervention. 
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Table 8 
Linear regression of moderating effects of baseline measures: LOCF 
 Moderation by baseline measure (N = 124) 
  Depression PANAS positive PANAS negative BAI 
BDI-II  B 95% CI p B 95% 
CI 
p B 95% CI p B 95% 
CI 
p 
 6-week 
follow-up 
-0.04 -0.39 to 
0.31 
.818 -0.10 -0.49 
to 0.29 
.611 0.20 -0.15 
to 0.54 
.258 .20 -0.05 
to 0.45 
.121 
 2-week 
follow-up 
-0.17 -0.50 to 
0.17 
.336 -0.02 -0.40 
to 0.35 
.909 -0.04 -0.37 
to 0.29 
.815 0.11 -0.14 
to 0.35 
.384 
 Post-
intervention 
-0.03 -0.27 to 
0.22 
.822 -0.22 -0.49 
to 0.05 
.109 -0.09 -0.33 
to 0.15 
.447 0.04 -0.13 
to 0.22 
.632 
Note. Bold font indicates significant effect at alpha level .05 
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Effects of Cognitive Bias Change on Mood 
 Linear regression analyses aimed at finding out whether changes in 
cognitive bias mediated changes in mood are summarised in Table 9; analysis 
using last observation carried forward for missing data was not appropriate. 
Change in threshold from baseline to last observation was a positive predictor 
of PANAS positive subscale scores both at 6 weeks follow-up (p = .013) and 
post-training (p <.01) at the 5% level of probability, and at 2 weeks follow-up at 
trend level (p = .055). No other analyses showed evidence of participants’ final 
observed cognitive bias threshold predicting any mood outcome measure 
Table 9 
Linear regression analysis of whether early changes in cognitive bias predicted 
mood 
  B 95% CI p 
BDI-II     
 6-week follow-up -0.50 -1.24 to 0.24 .179 
 2-week follow-up -0.32 -1.22 to 0.59 .486 
 Post-intervention -0.46 -1.18 to 0.26 .202 
PANAS positive     
 6-week follow-up 0.95 0.21 to 1.70 .013 
 2-week follow-up 0.75 -0.02 to 1.52 .055 
 Post-intervention 1.29 0.64 to 1.93 <.001 
PANAS negative     
 6-week follow-up -0.06 -0.58 to 0.45 .803 
 2-week follow-up 0.27 -0.40 to 0.95 .425 
 Post-intervention 0.27 -0.38 to 0.92 .404 
Note. Bold font indicates significant effect at alpha level .05  
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Discussion 
The present study is the first to evaluate, using an RCT, the 
effectiveness of a web-based version of the ERT in modifying negative biases 
for interpreting ambiguous facial expressions and reducing depressive 
symptoms in a sample of people with low mood. The study aimed to investigate 
whether this intervention showed signs of therapeutic benefit on participants 
with low mood as measured by the BDI-II, in addition to a shift in bias for 
identifying ambiguous faces as happy rather than sad, compared with a control 
group assigned to a sham-ERT.  
Effects of ERT on Mood 
There was no statistical evidence to support the primary hypothesis (a) 
that participants who accessed the ERT had fewer symptoms of depression as 
measured by the BDI-II, at 6 weeks follow-up, than those randomised to the 
control group. Furthermore, there was no evidence to support the secondary 
hypothesis (b) that participants in the training condition had fewer symptoms of 
depression at two other time-points, post-intervention and 2 weeks follow-up, as 
measured by the BDI-II, than the control group. There was also no evidence to 
support hypothesis (c) that participants in the training group had less negative 
mood, and more positive mood as measured by the PANAS, at three time-
points, post-intervention, 2 and 6 weeks follow-up, than the control group. 
Contrary to hypothesis (c) there was evidence that at 2 weeks follow-up the 
training group had significantly more negative mood as measured by the 
PANAS, than the control group. 
There are many possible explanations for why hypotheses (a) to (c) were 
not supported, i.e., no reduction in symptoms of depressive mood was found. 
The most parsimonious explanation is that the hypotheses were incorrect; the 
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ERT might not have a beneficial therapeutic effect on reducing depression. 
Another simple explanation is that the study design was unable to capture the 
effects; this is expanded upon in the section regarding study limitations.  
The null findings partially fit with results from the study by Penton-Voak 
and colleagues (2012) who found no evidence for the ERT reducing depressive 
symptoms, measured by the BDI-II and PANAS negative subscale. They did 
find a significant improvement in positive affect measured by the PANAS, 
however, which was not replicated in the present study. The explanation that 
non-significant results in the current study relate to incorrect hypotheses fits 
with findings from a meta-analysis in which the authors concluded there was no 
evidence of CBM interventions modifying depression, based on a non-
significant, small, unreliable effect (Hallion & Ruscio, 2011). The explanation 
that the hypotheses were incorrect does not fit with a more recent meta-analysis 
that found evidence that CBM-I paradigms decreased negative mood (Menne-
Lothmann et al., 2014). The meta-analysis found bigger effects when CBM-I 
paradigms encouraged participants to use mental imagery, which was not a 
feature of the present study. The hypothesis that a CBM paradigm, such as the 
ERT, might have therapeutic benefit for people with depression comes from 
theoretical models, linking negative biases with the aetiology and maintenance 
of the condition (e.g., Beck et al., 1979), and evidence that modifying negative 
biases might underpin mechanisms of therapeutic interventions such as CBT 
and antidepressants (Harmer et al., 2009). This could be described as a 
compelling rationale for the development of CBM interventions to treat 
depression. Indeed a CBM-I paradigm might prove effective in reducing 
symptoms of depression; however an effective target might be a different bias 
than interpretation of ambiguous facial expressions as targeted by the ERT. 
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CBM-I studies that have shown evidence of a reduction in symptoms of 
depression have used different paradigms, pairing ambiguous situations with a 
positive bias, and encouraging participants to imagine the situations as if they 
were directly involved, i.e., from a field perspective (e.g., Blackwell & Holmes, 
2010; Lang et al., 2012). The focus on processing situations from a field 
perspective fits with models of depression specifically emphasising a central 
role for negative self-referent schemata and information processing biases 
(Hughes et al., 2007), rather than generalised negative cognitive biases.  
The only significant finding regarding an effect of the ERT on mood was 
evidence that the training group had significantly lower mood at 2 weeks follow-
up. This could reflect a real finding or represent a Type II error, particularly as 
many analyses were carried out increasing this possibility. It is important to 
consider this might be a real effect indicating some participants who accessed 
the ERT did become lower in mood, highlighting a potential risk of psychological 
harm. Indeed, by supporting people with depression to have a more positive 
interpretation of other people’s ambiguous expressions, the ERT might actually 
reinforce negative self-referent interpretations, contributing to the vicious spiral 
of depression, e.g., everyone seems happy except me. 
Exploratory analyses showed that despite no significant improvement in 
positive affect being found in the present study, increases in positive affect were 
significantly mediated by increased positive bias, measured by change in ERT 
threshold. Moderation analyses suggested people with lower levels of baseline 
anxiety experienced an improved effect from training on lowering BDI-II score at 
6-week follow-up. Subjective reports of changes in mood captured by the 
acceptability measure included negative affect, anger, irritability, sadness, 
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boredom, and guilt, and positive affect, feeling more relaxed, sociable, happy, 
and less grumpy. 
Effects of ERT on Interpretation Bias 
The manipulation check showed significant evidence that the intervention 
was successful in modifying participants’ responses to the ERT, giving support 
for hypothesis (d) that participants in the training group showed a more positive 
bias for interpreting ambiguous facial expressions as happy than sad, as 
measured by the thresholds obtained at time-points after baseline, compared to 
the control group. This finding was expected in the context of previous studies 
that had informed the current study design (Brazil et al., 2012; Penton-Voak et 
al., 2012). Both previous studies investigated use of the ERT with people with 
dysphoria and found significant increases in positive bias as measured by 
change in ERT threshold, in laboratory conditions and when delivered via 
smartphones. 
Various explanations could explain the underlying mechanism by which 
the ERT has consistently been found to modify responses of people with low 
mood. These findings could indicate an increase in positive interpretation bias 
that had generalised to a range of ambiguous situations, or the findings might 
relate to a change in bias specific to processing ambiguous facial expressions. 
Indeed the stimuli used as the outcome measure were identical to the stimuli 
used in the training task; therefore, the measured change in positive bias might 
not transfer to different faces. Furthermore, the change in threshold might 
indicate a learned response, i.e., participants learned the “right” answer, rather 
than a change in appraisal of whether ambiguous expressions were happy or 
sad.  
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Acceptability of the ERT 
The overall impression based on adherence to the intervention and 
comments obtained from the acceptability questionnaire was that many 
participants found the ERT had a low level of acceptability. Adherence to the 
intervention was significantly lower for the training group than the control group. 
The only difference between training and control conditions was the feedback 
that encouraged participants in the training group to modify their responses. 
Arguably, this has some similarities to a CBT therapist challenging a client’s 
maladaptive thoughts, which if done in a persistent, non-empathic manner can 
be experienced as invalidating, perpetuating depressive schemas of feeling 
worthless (Katzow & Safran, 2007). Comments obtained on the acceptability 
questionnaire included many possible reasons why participants found difficulties 
in engaging with the ERT for five sessions. Issues contributing to low 
acceptability included the length of the task, which was programmed to be a 
maximum of 30 minutes and deemed to be too long, causing concentration 
difficulties and exacerbation of physical pain. The task was viewed as 
unengaging and unenjoyable particularly as stimuli were all very similar, one 
man’s face showing 15 subtly different expressions. Difficulties categorising the 
ambiguous expressions, having to process the images quickly, remembering 
and finding time to do the task, managing environmental distractions, and 
coping with feedback suggesting their judgment of emotions was incorrect were 
also described as challenges to acceptability of the intervention.  
Study Limitations 
Limitations of the study were related to the sample, intervention, outcome 
measures, and design.  
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Sample. 
There are many limitations related to the study sample. A high rate of 
attrition and small sample size caused a low level of power to detect small 
effects on symptoms of depression. Generalizability of the findings is restricted 
due to the sample being an analogue rather than clinical sample, most 
participants being female and from the UK, and strict inclusion criteria meaning 
no participant was receiving professional treatment for their dysphoria.  
The high rate of attrition was surprising when compared to low rates in 
previous studies using the ERT (Brazil et al., 2012; Penton-Voak et al., 2012). 
Factors influencing attrition could have been lack of motivation, a symptom of 
depression; people who lacked motivation would have been screened out by 
the previous studies where there was a requirement to attend the laboratory at 
the recruitment stage. Indeed the current study found participants who 
completed the ERT per-protocol had higher baseline levels of positive affect, 
associated with motivation, than those who did not adhere to the intervention. A 
further explanation for the attrition is that participants had an unrealistic 
expectation of what the research would entail, particularly as recruitment was 
opportunistic and not focused on people who had contact with a university. A 
lack of face-to-face contact and not enough email reminders is likely to have 
contributed to study dropout. Indeed, at the 6 week follow-up the researcher 
had time to send multiple reminders leading to more people completing 
questionnaires than at other follow-up time-points.  
There are many differences between the samples of participants 
recruited by the current web-based study and the laboratory-based intervention 
implemented by Penton-Voak and colleagues (2012), which could have 
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contributed to differences in the studies’ results: socio-demographic differences, 
face-to-face factors, and level of symptoms. 
Intervention. 
Limitations of the intervention related to being unable to check 
participants’ fidelity to the instructions; they might have asked someone else to 
do the task or not properly concentrated. Participants were only required to 
undertake five training sessions; however most did not complete even these. A 
ceiling effect occurred in shifting participants’ thresholds and there was a 
relatively high baseline threshold compared to the study by Penton-Voak and 
colleagues (2012).  
There were limited stimuli: only one face, which was male, was used. It is 
unclear what effect the exclusive use of white, male stimuli might have had on a 
sample of predominantly female participants and people from different ethnic 
backgrounds. Indeed results from an antidepressant study investigating male 
participants in Brazil found different interpretation responses to male and female 
stimuli (Alves-Neto, Guapo, Graeff, Deakin, & Del-Ben, 2010). Use of both male 
and female stimuli is therefore important for future studies. 
Presentation of stimuli in the current study was brief, 150ms exposure, 
which may be more beneficial for targeting unconscious information-processing 
biases which occur in anxiety than for targeting the more conscious biases 
which occur in depression (Teachman, Joormann, Steinman, Gotlib, 2012). 
Outcomes. 
Changes to specific symptoms related to low mood might not have been 
detected by the measures of mood, BDI-II and PANAS. The BDI-II might not 
capture symptom change relating to modifications of emotion recognition bias, a 
EFFECTS OF CBM-I ON DEPRESSION 
91 
measure for capturing changes in interpersonal relationships might be more 
appropriate. Indeed Adams and colleagues (2013) have proposed to measure 
change in number of close friends of participants in their future trial investigating 
the effect of ERT on participants with low mood. The BDI-II and PANAS might 
not have been sensitive in detecting small reductions of dysphoria. No 
independent measure of interpretation bias was used to check that the ERT had 
an effect that could be generalized beyond the training stimuli. Participants’ 
ERT thresholds were not measured at 2 and 6 week follow-up time-points to 
check durability of the effect. 
Study design. 
 Participants’ group allocation was revealed to the researcher during the 
study, leading to a risk that groups could have received differing interaction with 
the researcher via email. Participants could have guessed the hypothesis which 
could have influenced their responses.  
Study Strengths 
The current study had many strengths. It was an RCT that was carefully 
designed and conducted, and included two follow-up assessments. The study 
has been reported with the rigour outlined in the CONSORT checklist (Schulz, 
Altman, & Moher, 2010), ensuring transparency and replicability of the study. 
The control condition was very similar to the intervention, reducing the influence 
of confounding factors. The researcher carried out the study with a high regard 
for ethical issues, ensuring that participants were treated with respect and 
dignity. No face-to-face contact occurred throughout the study, enabling in vivo 
assessment of a treatment with potential to be delivered without face-to-face 
contact. The sample was an analogue group of people with low mood from a 
wide age range, more similar to a clinical population of people with depression 
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than a sample of young, healthy students. The design was based on a strong 
theoretical premise and laboratory evidence. A gold-standard self-report 
depression measure was used to assess change in mood, the BDI-II. 
Acceptability of the intervention was measured to inform future developments. 
Mediation analysis was carried out to investigate the proposed underlying 
mechanism, that changes in bias affect changes in mood. 
Clinical, Research, and Theoretical Implications 
 This study contributes to the growing field of CBM, specifically the 
development of the ERT as a potential intervention for depression. No evidence 
was found for the ERT having a beneficial effect on mood. The mechanism by 
which CBM interventions are proposed to treat depression is in reducing 
negative bias to mediate changes in mood. Mediation analysis in the current 
study gave some support for this model showing change in bias was positively 
related to change in affect, measured by the PANAS positive subscale; caution 
should be taken in interpreting these analyses because they were exploratory 
and do not necessarily indicate causation. Harmer and colleagues (2009) 
suggested a subtly different model where more positive emotion recognition 
biases, lead to better social interactions, followed by improvements in mood, 
creating a virtuous cycle; this model is being investigated in a current ERT study 
(Adams et al., 2013).  
Future studies using web-based designs with strict participant exclusion 
criteria should be aware of the large amount of time and resources required by 
researchers for the recruitment and screening of participants and prevention of 
attrition. Automation of further aspects of this study, such as daily emailed 
reminders to complete the ERT, could have encouraged greater participant 
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adherence to the intervention and enabled participant allocation to groups to 
have remained concealed until after all data had been collected. 
Exploratory analyses in the present study suggested two subgroups 
might have benefited more than other participants did from the ERT. Those with 
higher baseline levels of positive affect were more able to adhere to the 
intervention; those with lower baseline anxiety were more likely to obtain lower 
BDI-II scores at 6 weeks follow-up. Future CBM research, including studies 
investigating the ERT, should consider which subgroups of people might benefit 
more from interventions. 
Problems with acceptability of the ERT were highlighted in the current 
study. These issues could be helpfully considered when developing and 
modifying further interventions. There is a need to ensure tasks are engaging, 
do not cause harm, deterioration in mood or excessive discomfort. The most 
meaningful outcome measure could be reconsidered, perhaps the ERT might 
affect specific symptoms of depression. For example, Blackwell and colleagues 
(2014) did not find a CBM-I intervention improved symptoms of depression 
measured by the BDI-II but did find an improvement in symptoms of anhedonia 
measured by a specific selection of BDI-II items.  
The ERT intervention should be modified according to the feedback 
gathered by the acceptability measure and the study design refined before 
carrying out further studies. Future ERT research should investigate the 
generalizability of change in bias from specific ambiguous faces to other stimuli 
and tasks measuring interpretation bias. Evidence that change in bias related to 
the ERT is generalizable in addition to a replicable finding of reduction in 
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negative mood or improvement of positive affect should be found before 
investigating the use of the ERT on a clinical population.  
Conclusion 
The current study used a randomised controlled trial to investigate the 
effect of a web-based version of the ERT, a CBM-I intervention, on reducing 
symptoms of depression in people with low mood. Evidence of a more positive 
bias was found but no improvement in mood, compared to a control group. 
Future developments of the ERT should modify the intervention to increase 
acceptability, ensure generalizability of increased positive bias to different 
stimuli, and find evidence for consistent reductions in symptoms of depression 
before investigating its efficacy with a clinical population. 
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Appendix A: Acceptability Questionnaire for the ERT 
 
Please write as little or as much as you would like, in the spaces provided, in 
answer to questions 1 to 5. 
1. What did you think about the length of the emotion recognition training 
task? 
 
2. How enjoyable did you find the task? 
 
3. How engaging did you find the task? 
 
4. Did completing the task have an effect on your mood? 
 
5. Did you find the task challenging? 
 
6. Would you do the task again? Yes/No 
7. Were the task instructions easy to follow? Yes/No 
8. Would you recommend the task to a friend? Yes/No 
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Appendix B: Methods of Data Cleaning 
 
Data were initially checked for linearity and unusual cases using 
histograms, boxplots, and scatterplots, and by investigating the individual 
variables when transformed into z-scores. Scatterplots of outcome scores 
against baseline scores showed the linearity assumption to be reasonable, as 
expected. To reduce the impact of extreme outliers on the analysis, such scores 
were modified so that they were equal to 3.29*SD away from the pooled mean 
for that variable (as recommended by Tabachnick & Fidell, 2006). Reductions 
were made to the following cases: the BDI-II post-intervention score of one 
control participant; the PANAS negative subscale score of one training 
participant at 6 weeks follow-up, one training participant at two-weeks follow-up, 
and one training participant post-intervention; the baseline BAI score for one 
control participant and one training participant, the BAI score of one training 
participant at 6 weeks follow-up, the post-training BAI score of one control 
participant, and the baseline threshold of one training participant. 
The assumptions of linearity, homoscedasticity, normality, and 
independence of the residuals were also checked by plotting graphs with 
standardised scores of the predictor against standardised scores of the 
residuals, investigating histograms of the residuals, and using a Durbin-Watson 
analysis to check that scores were between 1 and 3. Checks were also 
performed to identify any excessive influence of multivariate outliers by 
checking that values of the Mahalanobis distance were less than 15 
(recommended by Field, 2013, for samples of less than 100) and that Cook’s 
distances were less than 1. Assumptions of normality and homoscedasticity 
were not met in one linear regression analysis relating to whether training 
EFFECTS OF CBM-I ON DEPRESSION 
104 
condition predicted PANAS negative subscale data at 2 weeks follow-up. This 
analysis also showed univariate and multivariate outliers. To increase the 
robustness of this analysis bootstrapped samples were created. The confidence 
intervals and standard errors generated from this bootstrapped regression 
analysis were reported. 
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Appendix C. Predictors Entered into Hierarchical Linear Regression Models 
 
Table A1 
Hierarchical linear regression models indicating how predictors were entered into each analysis. 
Analysis Outcome measure Initial predictor Second predictor Third predictor Fourth predictor 
Primary 
hypothesis (a) 
BDI-II 6-wk follow-up Baseline BDI-II Categorical 
predictor: Training 
group (1), control 
group (0). 
 
- - 
Secondary 
hypotheses (b) 
Secondary 
hypotheses (c) 
BDI-II 2-wk follow-up “ “ - - 
BDI-II post-intervention “ “ - - 
PANAS positive 6-wk follow-up Baseline PANAS 
positive 
“ - - 
PANAS positive 2-wk follow-up “ “ - - 
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PANAS positive post-intervention “ “ - - 
PANAS negative 6-wk follow-up Baseline PANAS 
negative 
“ - - 
PANAS negative 2-wk follow-up “ “ - - 
PANAS negative post-
intervention 
 
“ “ - - 
Exploratory 
analysis: Does 
group predict 
anxiety score? 
 
 
 
BAI 6-wk follow-up Baseline BAI “ - - 
BAI 2-wk follow-up “ “ - - 
BAI post-intervention “ “ - - 
Exploratory 
analysis: Does 
change in 
BDI-II 6-wk follow-up Baseline BDI-II Baseline ERT 
threshold 
Final observed 
ERT threshold 
- 
BDI-II 2-wk follow-up “ “ “ - 
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cognitive bias 
predict mood? 
BDI-II post-intervention “ “ “ - 
PANAS positive 6-wk follow-up Baseline PANAS 
positive 
“ “ - 
PANAS positive 2-wk follow-up “ “ “ - 
PANAS positive post-intervention “ “ “ - 
PANAS negative 6-wk follow-up Baseline PANAS 
negative 
“ “ - 
PANAS negative 2-wk follow-up “ “ “ - 
PANAS negative post-
intervention 
 
“ “ “ - 
Exploratory 
analysis: 
Moderation by 
baseline 
depression 
BDI-II 6-wk follow-up Baseline BDI-II Categorical 
predictor: Training 
group (1), control 
group (0). 
Interaction of 
baseline BDI-II 
score by group^ 
- 
BDI-II 2-wk follow-up “ “ “ - 
BDI-II post-intervention “ “ “ - 
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Exploratory 
analysis: 
Moderation by 
baseline 
anxiety 
BDI-II 6-wk follow-up “ “ Baseline BAI Interaction of 
baseline BAI 
score by group^ 
BDI-II 2-wk follow-up “ “ “ “ 
BDI-II post-intervention “ “ “ “ 
Note. ^ = The interaction predictor was created by generating centred predictors of the baseline score and condition (i.e., 
group) and multiplying them together. Centred predictors were created to meet assumptions of multi-collinearity by subtracting 
the pooled mean of the predictors. 
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Appendix D: Correlations between Outcome Measures 
Table A2 
Correlations between measures for the training group 
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BDI-II Pre 1.00                   
BDI-II Post .66** 1.00                  
BDI-II 2-wk  .47** .69** 1.00                 
BDI-II 6-wk  .48** .71** .80** 1.00                
PANAS +ve Pre  -.15 -.12 -.11 -.14 1.00               
PANAS +ve Post .14 -.22 -.41 -.34 -.26 1.00              
PANAS +ve 2-wk  -.09 -.24 -.55** -.50** .50** .85** 1.00             
PANAS +ve 6-wk  -.20 -.42* -.42* -.46** -.46** .64** .74** 1.00            
PANAS -ve Pre  .40** .45* .30 .33* .12 .10 .21 .23 1.00           
PANAS -ve Post .45* .48* .49* .39 -.07 .07 .15 .15 .59** 1.00          
PANAS -ve 2-wk  .32 .72** .59** .59** .04 -.14 -.12 -.09 .59** .84** 1.00         
PANAS -ve 6-wk  .27 .57** .50** .59** -.07 .07 -.11 -.02 .68** .77** .73** 1.00        
BAI Pre  .41** .38 .41* .41* .04 .02 -.21 .03 .51** .35 .38* .59** 1.00       
BAI Post .46* .76** .63** .65** -.04 -.06 -.03 -.08 .54** .55** .81** .62** .69** 1.00      
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BAI 2-wk  .35* .74** .61** .59** -.31 -.21 -.32 -.40* .26 .58** .58** .51** .57** .92** 1.00     
BAI 6-wk  .38* .76** .56** .62** -.10 -.15 -.26 -.13 .43** .56** .64** .65** .61** .86** .86** 1.00    
Threshold Pre -.17 -.43* -.09 -.14 .30* .04 .17 .09 -.03 -.15 -.05 -.18 -.10 -.26 -.20 -.33* 1.00   
Threshold Final obs .20 .02 -.16 -.17 .22 .64** .52** .38* .15 .17 .14 .04 .02 .24 -.09 -.04 .23 1.00  
Age .03 -.21 -.08 -.16 .32** .12 .19 .26 .08 -.11 -.21 -.10 -.01 -.40* -.30 -.18 .26 .13 1.00 
Note. Pairwise analysis. Bold * = p < .05; Bold ** = p < .01. 
Table A3 
Correlations between measures for the control group 
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BDI-II Pre 1.00                   
BDI-II Post .74** 1.00                  
BDI-II 2-wk  .78** .81** 1.00                 
BDI-II 6-wk  .64** .66** .91** 1.00                
PANAS +ve Pre  -.40** -.05 -.23 -.14 1.00               
PANAS +ve Post -.26 -.40* -.39 -.27 .57** 1.00              
PANAS +ve 2-wk  -.14 -.22 -.39* -.38* .37 .71** 1.00             
PANAS +ve 6-wk  -.12 -.20 -.35 -.37* .33* .57** .72** 1.00            
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PANAS -ve Pre  .56** .51** .47* .36* -.04 -.01 .16 .15 1.00           
PANAS -ve Post .15 .41* .26 .28 .19 .10 .19 .14 .47** 1.00          
PANAS -ve 2-wk  .37 .46* .50** .34 .23 .03 .00 .01 .71** .71** 1.00         
PANAS -ve 6-wk  .35* .30 .46* .49** .17 .25 .11 .08 .58** .56** .60** 1.00        
BAI Pre  .53** .30 .28 .19 -.14 .01 .00 .05 .41** .28 .18 .28 1.00       
BAI Post .40* .39* .01 .09 -.04 -.05 .18 .06 .34 .47** .22 .25 .88** 1.00      
BAI 2-wk  .40* .27 .40* .25 .18 .19 -.10 -.16 .36 .54** .54** .26 .69** .76** 1.00     
BAI 6-wk  .52** .27 .42* .40** .01 .15 .07 -.16 .35* .46** .47* .50** .74** .67** .76** 1.00    
Threshold Pre -.11 -.02 -.26 -.24 .37** .26 .23 .08 .13 .09 .12 .31 .17 .15 .26 .20 1.00   
Threshold Final obs -.17 -.16 -.29 -.29 .42** .32 .09 .11 -.12 .00 -.10 -.04 .09 .06 .12 .11 .69** 1.00  
Age -.23 -.05 -.04 .05 .36** .23 .04 -.06 -.04 -.20 -.22 -.07 -.28* -.42* -.20 -.14 -.03 .11 1.00 
Note. Pairwise analysis. Bold * = p < .05; Bold ** = p < .01. 
 
  
EFFECTS OF CBM-I ON DEPRESSION 
112 
Appendix E: Missing Data Comparisons 
Table A4 
A comparison of characteristics of participants from whom questionnaire responses were and were not obtained post-
intervention 
Baseline measure Post-intervention responders 
(Training: N = 26; Control: N = 33) 
Missing data 
(Training: N = 40; Control N = 25) 
  
  Mean (SD) Mean (SD) F p 
PANAS: Positive Training 19.50 (7.13) 18.78 (7.05) 0.17 .686 
 Control 19.15 (5.51) 20.60 (7.01) 0.78 .382 
PANAS: Negative Training 18.15 (7.03) 18.73 (7.50) 0.10 .758 
 Control 19.03 (7.32) 18.96 (7.39) <0.01 .971 
BDI-II Training 21.73 (6.94) 21.75 (5.78) <0.01 .990 
 Control 24.21 (8.39) 21.88 (7.96) 1.15 .288 
BAI Training 17.46 (8.65) 18.73 (9.37) 0.30 .583 
 Control 16.06 (11.46) 17.60 (9.77) 0.29 .592 
ERT 
Threshold(24 v 
34) 
Training 8.67 (1.13) 8.35 (1.32) 0.89 .349 
31v18 Control 7.84 (1.32) 8.94 (1.43) 7.51 .009 
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Age Training 42.42 (13.15) 41.30 (13.28) 0.11 .737 
 Control 40.45 (13.43) 41.52 (13.16) 0.09 .764 
Note. Bold font indicates significant effect at alpha level .05 
Table A5 
A comparison of characteristics of participants from whom questionnaire responses were and were not obtained at 2 weeks 
follow-up 
Baseline measure 2 week follow-up responders 
(Training: N = 37; Control: N = 28) 
Missing data 
(Training: N = 29; Control N = 30) 
  
  Mean (SD) Mean (SD) F p 
PANAS: Positive Training 19.65 (7.42) 18.31 (6.56) 0.59 .447 
 Control 19.96 (5.90) 19.60 (6.54) 0.05 .825 
PANAS: Negative Training 18.70 (7.28) 18.24 (7.38) 0.07 .800 
 Control 19.86 (7.87) 18.20 (6.73) 0.75 .391 
BDI-II Training 21.86 (6.51) 21.59 (5.91) 0.03 .858 
 Control 24.18 (8.07) 22.30 (8.38) 0.75 .389 
BAI Training 19.78 (7.29) 16.24 (10.69) 2.55 .115 
 Control 15.61 (9.28) 17.77 (11.93) 0.59 .447 
ERT Threshold Training 8.51 (1.07) 8.43 (1.50) 0.06 .814 
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35v23 
26v23 Control 7.77 (1.24) 8.78 (1.51) 6.65 .013 
Age Training 40.79 (12.53) 42.49 (13.73) 0.27 .607 
 Control 41.86 (13.51) 40.03 (13.09) 0.27 .604 
Note. Bold font indicates significant effect at alpha level .05 
Table A6 
A comparison of characteristics of participants from whom questionnaire responses were and were not obtained at 6 weeks 
follow-up 
Baseline measure 6 week follow-up responders 
(Training: N = 44; Control: N = 43) 
Missing data 
(Training: N = 22; Control N = 15) 
  
  Mean (SD) Mean (SD) F p 
PANAS: Positive Training 20.20 (7.56) 16.77 (5.27) 3.63 .061 
 Control 19.65 (5.71) 20.13 (7.60) 0.07 .797 
PANAS: Negative Training 19.00 (7.73) 17.50 (6.32) 0.62 .434 
 Control 19.51 (7.67) 17.53 (6.03) 0.82 .370 
BDI-II Training 21.80 (6.68) 21.64 (5.28) <0.01 .923 
 Control 24.07 (8.66) 20.73 (6.40) 1.86 .178 
BAI Training 19.11 (9.54) 16.45 (7.88) 1.27 .264 
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 Control 16.72 (10.96) 16.73 (10.27) <0.01 .997 
ERT Threshold Training 8.67 (1.03) 8.00 (1.63) 3.46 .068 
39v10 Control 8.15 (1.55) 8.60 (0.97) 0.75 .391 
Age Training 44.00 (13.14) 37.23 (12.20) 4.08 .048 
 Control 40.98 (13.25) 40.73 (13.55) <0.01 .952 
Note. Bold font indicates significant effect at alpha level .05 
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Appendix F: ERT Adherence and Thresholds 
Table A7 
Adherence to the ERT and thresholds of participants over five sessions 
Participants from whom post-training thresholds 
were obtained 
Threshold for distinguishing happy vs sad faces 
Treatment group (N = 66) Control group (N = 58) Training group Control Group 
N (%) N (%) Pre M (SD (N)) Post M (SD (N)) Pre M (SD (N)) Post M (SD (N)) 
Day 1 40 (60.61) 43 (74.14) 8.48 (1.25 (58)) 9.90 (1.80 (40)) 8.24 (1.45 (49)) 8.30 (1.68 (43)) 
Day 2  28 (42.42) 32 (55.17) 10.41 (2.06 (39)) 11.75 (2.08 (28)) 8.22 (1.86 (37)) 8.22 (1.77 (32)) 
Day 3 23 (34.85) 26 (44.83) 11.08 (2.02 (24)) 11.78 (2.13 (23)) 8.83 (1.95 (29)) 8.77 (1.93 (26)) 
Day 4 19 (28.79) 22 (37.93) 11.90 (2.00 (20)) 12.00 (2.38 (19)) 8.76 (2.11 (25)) 9.00 (2.20 (22)) 
Day 5 12 (18.18) 19 (32.76) 12.00 (2.54 (14)) 11.50 (2.78 (12)) 8.52 (1.99 (21)) 8.63 (2.06 (19)) 
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Appendix G: Ethics Letter of Approval 
From: apache@exeter.ac.uk <apache@exeter.ac.uk> on behalf of Ethics Approval 
System <D.M.Salway@exeter.ac.uk> 
Sent: 19 June 2013 13:09 
To: Stephens, Victoria 
Subject: Your application for ethical approval (2013/377) has been accepted 
  
Ethical Approval system 
 
Your application (2013/377) entitled Effects on depressive symptoms following use of an 
internet-based programme aimed at modifying emotion recognition has been accepted 
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Appendix H: Study Information Sheet 
 
Emotion Recognition Training Screening Survey 
Study Information 
Emotion Recognition Training Using an Internet-Based Programme 
 
Researcher: Vick Stephens, University of Exeter, Trainee Clinical 
Psychologist. Supervisors: Professor Marcus Munafò, Professor Ian Penton-Voak, 
School of Psychology, University of Bristol 
 
You are being invited to take part in a research study and it is important for you to 
understand why the research is being done and what it will involve before you decide 
whether to take part. Please take your time to read the following information carefully 
and discuss it with your friends, relatives or GP if you wish. Please contact Vick 
Stephens (lead researcher) if there is anything that is unclear or if you would like more 
information: vs9494@bristol.ac.uk 
 
Please take your time in deciding whether or not you would like to take part. Thank you 
for your time. 
 
What is the purpose of this research? 
This research project will investigate a newly developed internet-based programme for 
emotion recognition training and its effects on individuals showing signs of low mood. 
 
Why have I been invited to take part and how is this research useful? 
We need to find people from the general public to test the internet-based emotion 
recognition training programme to investigate whether it shows potential benefits for 
helping people who have difficulties relating to mood. It is important to test new 
products on the general population before a clinical population. 
 
Do I have to take part?  
No, it is up to you whether you take part. You are free to change your mind at any time 
during the study without giving a reason, until the data analysis begins in 2014. 
 
What are the requirements to take part? 
In order to take part you should be aged 18 or over and have English as your first 
language or have an equivalent level of fluency. 
You would not be able to take part in the study if you are currently using illicit drugs 
[other than cannabis] or are dependent on drugs [other than nicotine and caffeine]. 
You should not take part if you have significant current or past psychiatric illness 
[except depression]. In addition, you should not take part if you are currently using 
psychiatric medication or have used psychiatric medication in the last 5 weeks. If you 
are unsure whether you fit these requirements, please contact Vick Stephens (lead 
researcher) vs9494@bristol.ac.uk. 
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What's involved?  
If you decide to take part you will be directed to a website where you will be asked if 
you would like to consent to taking part in the study. Participation in this study is 
entirely voluntary. It is up to you to decide whether or not to do this. If you decide not to 
take part, or to withdraw, you do not have to give a reason - nobody would be upset. 
You will also be asked to answer some questions to check your eligibility for the study. 
If you are found to be eligible, the research will involve you using an internet-based 
emotion recognition training programme, on 5 occasions, preferably on 5 consecutive 
days (each training session will take approximately 15 minutes). You will also be asked 
to complete online questionnaires, which relate to your mood, before and after the 5 
training sessions, and again two weeks and six weeks later.  
You will be offered an opportunity to take part in a raffle to win vouchers to the value of 
£10, £15, £20, £30 or £50; you will be able to enter the raffle even if you decide to 
withdraw from the study. 
 
What are the possible disadvantages and risks of participating in this research? 
There is no identified risk in taking part in this study. 
 
Your data 
All data will be kept entirely confidential throughout the study and anonymised (i.e. 
identifying personal details would be removed) on completion of the study. It would not 
be possible to identify you from any aspect of reporting for this research study. No 
individual data will be reported. 
 
What will happen to the results of the research study? 
When the study has been completed, the data will be analysed and the findings 
reported in accordance with the guidelines for submitting a major research project for 
the University of Exeter Doctorate in Clinical Psychology. The findings will also be 
reported in an appropriate scientific journal or presented at a scientific meeting. You 
would not be identified in any way. If you would like a copy of the final paper, you may 
request this. 
 
Who has reviewed the study? 
This study has been reviewed and approved of by the University of Exeter Psychology 
Research Ethics Committee. 
 
Who can I contact for further information? 
For further queries, please contact Vick Stephens (lead researcher): 
vs9494@bristol.ac.uk 
 
If you have any concerns related to your participation in this study please direct them to 
the Research Ethics Committee via Dr Cris Burgess, c.n.w.burgess@ex.ac.uk  
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Appendix I: Consent Form 
1. Please answer the following questions. 
 
a. Have you been given information which explains the study? Yes/No 
b. Have you had an opportunity to ask questions and discuss the study? 
Yes/No 
c. Have you received enough information about the study for you to make a 
decision about your participation? Yes/No 
d. Do you understand that you are free to withdraw from the study, without 
having to give a reason, at any time? Yes/No 
 
Please read the following statements and indicate below whether you agree or 
disagree. 
2. I hereby fully and freely consent to my participation in this study. I 
understand the nature and purpose of the procedures involved in this 
study. I understand and acknowledge that the investigation is designed 
to promote scientific knowledge and that the the data I provide will be 
used for no purpose other than research. I understand that the data I 
provide will be anonymised. I agree to the University of Bristol keeping 
and processing the data I provide during the course of this study. I 
understand that these data will be used only for the purpose set out in 
the information sheet, and my consent is conditional upon the University 
complying with its duties and obligations under the Data Protection Act. 
I agree  I disagree  
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Appendix J: Debriefing Information 
Study Debriefing Information  
Researcher Vick Stephens, Trainee Clinical Psychologist, University of Exeter: 
vs9494@bristol.ac.uk 
Title of Research. Effects on Depressive Symptoms Following Use of an Internet-Based Programme 
Aimed at Modifying Emotion Recognition. 
Background. Research shows that people who have depression generally have negative views 
(biases) about themselves, other people, the world, and the future. It can be helpful to change these 
negative biases to treat the depression and stop it from returning. Therapies like cognitive-behaviour 
therapy (CBT) seem to work by modifying negative biases, some research suggests that 
antidepressants also work in this manner.  
Further research has found that people with depression have a negative bias in recognising facial 
expressions of emotions, i.e., a tendency to judge ambiguous facial expressions as sad rather than 
happy. Computerised training programs (similar to the one used in this study) can be used to modify 
this bias, i.e., training people to judge ambiguous faces as happy rather than sad. Furthermore, 
modification of these biases in emotion recognition could potentially reduce levels of depression. 
Some research has shown that people who have used the computer program in a laboratory setting 
have received beneficial effects. The aim of this research project is to investigate whether beneficial 
results can also be found in a more real-world setting, where people have accessed the training 
program more independently via the internet.  
I plan to present the findings of this research at a conference in the summer of June 2014 and also in 
a scientific journal. 
Depression is a major cause of disability and a quarter of the population may experience at least one 
depression episode in their lifetime. Computer technologies have great potential for providing 
inexpensive interventions for mental health conditions, and can contribute to the treatments that are 
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available for depression to ensure more people can receive help which can be accessed easily.  
Please talk to your GP or a counsellor if your own mood is particularly low for any reason.  
There are many helplines that you can contact: e.g., the Support Line Telephone Helpline, 01708 
765200. http://www.supportline.org.uk/  
or The Samaritans, 08457 90 90 90, jo@samaritans.org http://www.samaritans.org/ 
Useful self-help and coping tips for dealing with low mood and depression can be found on: 
www.helpguide.org/mental/depression_tips.htm    
Thank you for taking part in this study. 
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Appendix K: Dissemination Statement 
The target journal for this research is the British Journal of Psychiatry. 
The paper will be adapted to the relevant style and sent for peer review. A 
summary of the findings will be sent to all people who expressed an interest, at 
the recruitment stage, in being informed of the results. A summary of the 
research will also be placed on social media sites that were used for 
recruitment. The thesis will also be made universally accessible through Open 
Research Exeter (ORE), the online institutional repository. 
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